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1 General introduction 
 
In 1628, the English physician William Harvey published his seminal book, Exercitatio 
Anatomica de Motu Cordis et Sanguinis in Animalibus. He could prove by a simple 
experiment that blood circulates throughout the body by a connected system of capillaries 
and is constantly pumped by the heart. His opus replaced the previous theory of the Greek 
physician Galen of Pergamon, who claimed that arterial blood originates in the heart and 
venous blood in the liver, from where it gets distributed to the rest of the body.  
The functionality of the organism rests on the adequate supply of oxygen and nutrients to the 
different organs and parts of the body, assuming a constant flow and circulation of blood. 
Beyond that, the advanced understanding of blood flow, vasculature, and endothelial lining 
points at something far more complex than Harvey's theory.  
 
The inner lining of blood vessels and lymphatics consists of a thin monolayer of polygonal 
flattened endothelial cells. In adults, the amount of endothelial cells is approximately 1 to 6 x 
1013. In summary they weigh 1 kg and have a total surface of 1 to 7 m2 (Cines et al., 1998). 
Endothelial cells exhibit a barrier between the blood flow and the surrounding tissue and play 
a crucial and active role in the maintenance of the vascular homeostasis. They regulate a 
variety of complex biological processes, such as hemostasis, blood coagulation, regulation of 
vascular smooth muscle tone, angiogenesis, immune response, and inflammatory processes 
including migration of leukocytes. Endothelial cell function requires the constant response to 
physical and chemical stimuli of circulating blood cells, and the release of a broad spectrum 
of paracrine and autocrine factors (Sumpio et al., 2002; Verma et al., 2003). 
Another key function of vascular endothelial cells is the selective and bidirectional exchange 
of macromolecules, small molecules, and water between the luminal and abluminal side of 
capillaries (Verma et al., 2003). The size-specific selection is necessary to establish a protein 
gradient which is in turn essential for the maintenance of the fluid balance between blood 
and tissue, and depends on both the molecular radius of the transported molecules and the 
composition of the particular endothelial barrier (Mehta and Malik, 2006). One plasma protein 
turns out to be especially important in this process, namely albumin, given that this protein 
facilitates the co-transport of other hydrophobic molecules such as lipids and hormones 
across the endothelial wall due to its molecular structure and electric charge (Mehta and 
Malik, 2006). In general, different strategies arise for endothelial cells to accomplish such a 
specific transport of molecules.  
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1.1 Transport mechanisms across endothelial cells 
 
1.1.1 Paracellular transport 
 
The paracellular transport describes the passage of small molecules, water and ions 
between neighboring cells across the endothelial barrier (Figure 1). This restricted 
permeability is sustained by interendothelial junctions, such as tight junctions, gap junctions, 
and adherens junctions. Tight junctions and adherens junctions impede the uncontrolled 
penetration of large molecules by attaching neighboring cells, whereas gap junctions form 
paracellular channels which allow and facilitate the passage of small molecules, water and 
ions (Komarova and Malik, 2010).  
 
 
Figure 1: Paracellular and transcellular pathways to overcome the endothelial barrier. A, Small molecules, 
such as water and ions are transported via the paracellular route from the apical side to the basolateral side of the 
cell. Tight junctions and adherens junctions allow the passage of small molecules between neighboring cells. B, 
Transcellular transport involves membrane-bound vesicles which detach from the plasma membrane and 
transport molecules from the apical membrane to the basolateral side were they fuse again with the plasma 
membrane and release their cargo. This transport can be either by receptor-mediated transcytosis or by fluid-
phase transcytosis. 
 
 
1.1.2 Transcellular transport 
 
The process of transcytosis was first described by Palade in the year 1950 during his studies 
on the permeability of blood capillaries. However, the term transcytosis was characterized by 
Simionescu in the year 1979 (Tuma and Hubbard, 2003). Transcytosis is defined by the 
process of transporting albumin from the luminal side of a capillary to the subendothelial 
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space (Minshall et al., 2002; Tuma and Hubbard, 2003). As already mentioned, besides 
albumin, other macromolecules such as albumin-binding ligands, insulin, lipids, and 
hormones are transported via transcytosis (Frank et al., 2003a; Minshall et al., 2002). 
Soluble plasma molecules can be taken up together with blood plasma, a process called 
fluid-phase transcytosis, or by receptor-mediated transcytosis which requires a specific 
binding of the molecule to a membrane-bound receptor (Tuma and Hubbard, 2003) (Figure 
1). Transcytosis is an energy-dependent transport which takes place by means of 
membrane-bound vesicles. To transport molecules within the cell, they need to get 
internalized at the plasma membrane. Specialized cells, commonly referred to as 
phagocytes, such as macrophages, monocytes, neutrophils, and dendritic cells can 
internalize substances via phagocytosis, an important mechanism in terms of defense 
against infectious agents (i.e. bacteria and viruses). However, in most cell types the main 
mechanism to internalize molecules is via endocytosis. Endocytosis is defined as the 
process in which molecules get engulfed in coated vesicles that are formed at the plasma 
membrane. So far, there are three different types of coated vesicles, the Clathrin-coated, the 
CopI-coated, and the CopII-coated vesicles. Among those, Clathrin-coated vesicles are the 
best studied type so far. After formation at the plasma membrane, the vesicles detach from 
the membrane along with the engulfed molecules. Shortly after detaching, the clathrin-
covering gets discarded and the transport vesicles migrate to their target compartment and 
fuse with the membrane. First they reach the early endosome than the late endosome and 
finally the lysosome.  
Lately, the spotlight has been put on a clathrin-independent mechanism as well, namely the 
caveolae-mediated endocytosis (Pelkmans and Helenius, 2002).  
 
 
1.1.2.1 Caveolae 
 
In turn, the pioneering work was done by Palade and Yamada. During his observations of 
semithin sections from continuous lung endothelia, Palade discovered the existence of cell 
invaginations with a "cave-like" morphology in the early 1950s. The "cave-like" appearance 
gave this newly discovered cellular structure the name caveolae. 
Caveolae are spherical, omega-shaped cell invaginations of the plasma membrane with a 
mean diameter of 50-80 nm (Figure 2A and B). They are also called non-coated or smooth-
coated plasmalemmal invaginations, because they lack a cytoplasmic coat which is a typical 
feature of clathrin-coated pits (Gumbleton et al., 2000). Caveolae are thought to arise from 
lipid rafts, areas at the plasma membrane which are rich in cholesterin, glycosphingolipids, 
and GPI-anchoring proteins. Caveolae are very common and appear in many highly 
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differentiated mammalian cell types with some exceptions such as red blood cells, 
thrombocytes, lymphocytes, and neuronal cells (Fra et al., 1995). Caveolae tend to appear in 
clusters, but they are also found as single pits. Recent studies have shown that caveolae are 
involved in cellular transport and human diseases such as cancer, muscular dystrophy, 
Alzheimer's disease, and atherosclerosis (Engelman et al., 1998; Frank, 2010). A big step in 
the research of caveolae was the discovery of caveolin, the main structural protein of 
caveolae (Rothberg et al., 1992). Caveolin, now referred to as caveolin-1 is an integral 
membrane protein which is part of a protein family with at least three members in 
vertebrates: caveolin-1, caveolin-2, and caveolin-3 (Glenney, 1992; Rothberg et al., 1992; 
Scherer et al., 1996; Tang et al., 1996). Caveolin-1 and caveolin-2 are highly expressed in 
endothelial cells, adipocytes, and type I pneumocytes, Caveolin-3 is only expressed in cells 
of skeletal and cardiac muscle (Scherer et al., 1996, 1994; Tang et al., 1996), whereas in 
smooth muscle cells all protein members are present (Tang et al., 1996). Like clathrin-coated 
vesicles, caveolae are capable of engulfing molecules and detaching from the plasma 
membrane. Unlike clathrin-coated vesicles, caveolae can migrate from the luminal to the 
abluminal side of the cell where they release their cargo, a scenario which has been shown 
by perfusion with varying tracer molecules (Predescu et al., 1997; Simionescu et al., 1975). 
In addition, similar to phagocytes, caveolae are able to take up viruses and bacteria, and to 
deliver them from the cell surface to intracellular compartments for degradation (Anderson et 
al., 1996; Montesano et al., 1982; Shin et al., 2000). In most endothelial cells, caveolae are 
more common than clathrin-coated pits. The highest number of caveolae are found in 
endothelial cells of heart, lung and skeletal muscle (Aird, 2007a).  
 
 
1.1.2.2 Transendothelial channels 
 
Transendothelial channels (TECs) are openings which span the entire cell from the luminal to 
the abluminal side (Figure 2B and C). They are most likely formed either by the fusion of a 
caveola with the luminal and abluminal plasma membrane, or by the fusion of 2 to 4 
caveolae (Stan, 2000). After application of VEGF, Chen et al. demonstrated an enrichment of 
caveolae in HUVEC (human umbilical vein endothelial cells), followed by the fusion of 
caveolae to transendothelial channels (Chen et al., 2002).  
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1.1.2.3 Vesiculo-vacuolar organelles (VVOs) 
 
The term vesicular-vacuolar organelles (VVOs) represents the fusion or cluster of several 
caveolae (Figure 2D). VVOs are evident in endothelial cells of arterioles, capillaries, and 
most commonly in venular endothelium (Feng et al., 2002), are capable of spanning the 
entire thickness of the cell and can form groups of more than 100 single caveolae (Dvorak 
and Feng, 2001). 
 
 
Figure 2: Endothelial cell organelles. Transmission electron micrographs of endothelial subcellular structures. 
A, Caveola with a stomatal diaphragm. B, Endothelial cell showing caveolae on the abluminal side of the cell 
(boxed area on the left) and a transendothelial channel (boxed area on the right). C, Electron micrograph of a 
transendothelial channel (TEC) with two diaphragms on both sides. D, Endothelial cell presenting vesiculo-
vacuolar organelles. Pictures in A, C and D are taken from Radu V Stan, 2007. 
 
 
1.2 Endothelial Heterogeneity 
 
Vascular endothelial cells of different vascular beds are remarkably heterogeneous with 
respect to their structural and functional properties. This heterogeneity is based on the 
different needs for permeability of water and solutes in the different vascular beds (Aird, 
2007a, 2007b). Endothelial cells are either discontinuous or continuous.  
 
 
1.2.1 Discontinuous endothelium 
 
Discontinuous endothelial cells are evident in vascular beds such as the bone marrow, the 
spleen, but most notably the liver (Figure 3B). They are characterized by large circular 
openings with mean diameters of 100-300nm - depending on the species - and the absence 
of a basal lamina (Braet and Wisse, 2002). In the liver, sinusoidal pores function as a 
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dynamic biofilter, which separates macromolecules of different sizes, mainly lipoproteins, 
between the sinusoidal lumen and space of Disse (Fraser et al., 1995). 
 
 
Figure 3: Endothelial heterogeneity. Schematic cross sections of the three basic types of blood capillaries. A, 
Continuous endothelium with endothelial cells linked by tight junctions and underlying continuous basal 
membrane. Continuous endothelial cells are found in brain tissue, skin, heart and lung and typically contain 
numerous caveolae. B, Discontinuous endothelium is characterized by the presence of large circular open pores 
with a mean diameter of 100-300 nm and by the absence of a basal lamina. Discontinuous endothelial cells are 
evident in vascular beds such as liver and bone marrow. C, Characteristic for fenestrated endothelial cells are 
transcellular pores with a mean diameter of 62-68 nm which are, depending on the vascular bed, bridged by a 
fenestral diaphragm. (Modified after Benninghoff and Drenckhahn, 2003). 
 
 
1.2.2 Continuous endothelium 
 
Continuous endothelial cells can be further classified into non-fenestrated or fenestrated 
endothelia (Tse and Stan, 2010). Non-fenestrated continuous endothelial cells are commonly 
found in capillaries of the brain, skin, heart, and lung (Figure 3A). The endothelial cells are 
connected by tight junctions and supported by an underlining continuous basal membrane.  
 
 
1.2.3 Fenestrated endothelium 
 
Fenestrated endothelial cells (Figure 3C) are also associated with a continuous basal 
membrane and are located in capillaries of the intestinal villi, peritubular capillaries of the 
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kidney, exocrine and endocrine glands, or the choriocapillaris in the eye, all organs with a 
substantial need for filtration and transendothelial transport. The structural hallmark is the 
presence of pores or fenestrae.  
 
 
1.2.3.1 Fenestrae 
 
Fenestrae are transcellular circular openings with a constant diameter of 62-68 nm which 
extend the entire thickness of the cells (Clementi and Palade, 1969a, 1969b; Simionescu et 
al., 1974). Fenestrae are arranged in so called sieve plates, large clusters of individual 
fenestrae. The density of fenestrae varies depending on the vascular bed. For example, in 
the kidney cortex 8.35 % of total endothelial surface is occupied by fenestrations, in contrast 
to the exocrine pancreas with only 3.68 % (Milici et al., 1985).  
 
Depending on the particular vascular bed, caveolae, VVOs, TECs, and fenestrae are 
characteristically bridged by a thin 5 to 6 nm non-membranous diaphragm (Clementi and 
Palade, 1969c; Friederici, 1969, 1968a). Caveolae and TECs are covered by a stomatal 
diaphragm, fenestrae by a fenestral diaphragm (Figure 3C), both similar in regard to their 
structure. The diaphragm may qualify these structures with increased size and charge 
selectivity, allowing only small molecules and limited amounts of plasma to pass (Aird, 
2007a; Palade et al., 1981; Simionescu et al., 1981b, 1981c). In vitro studies could show that 
factors like vascular endothelial growth factor (VEGF), extracellular signals (i.e. TGFβ, 
serotonin, retinoic acid), phorbol myristate acetate (PMA), cytochalasin B, calcium ions, or 
extracellular matrix components influence fenestrae formation (Carley et al., 1988; Esser et 
al., 1998a; Gatmaitan et al., 1996; Lombardi et al., 1988, 1986; McGuire et al., 1992; Milici et 
al., 1985; Steffan et al., 1987). Especially VEGF has been shown to be able to induce 
fenestrae formation. For instance, Roberts and Palade have shown that the topical 
application of VEGF to the rat cremaster muscle or subcutaneous injection in the skin 
induced the formation of fenestrae in these tissues, which do not contain fenestrae naturally. 
Furthermore, fenestrae induction was reported to appear after only 10 min exposure in situ, 
indicating that the molecular "ingredients" for the formation of diaphragms are already 
available, given that exposure time was too short for de novo protein synthesis (Roberts and 
Palade, 1995). However, the importance of VEGF in fenestrae formation is not generally 
accepted. Several studies in recent decades presented controversial results (Hofman et al., 
2000; Kohn et al., 1992; Vasile et al., 1999). 
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Besides fenestrated vascular beds, also endothelial cells of Schlemm's canal endothelium 
possess fenestrae-like pores. The inner wall of Schlemm's canal (SC) shows one of the 
highest hydraulic conductivities throughout the body allowing the aqueous humor to exit the 
eye by passing the trabecular meshwork and entering the lumen of Schlemm's canal. The 
high hydraulic conductivity requires the formation of large intracellular (I-pores) and 
intercellular pores (B-pores) with diameters of 0.1 to 2 µm (Johnson, 2006). Solitary 
minipores which were found in SC endothelial cells of monkey and human eyes (Inomata et 
al., 1972; Tamm, 2009a) are very similar to diaphragmed fenestrae of fenestrated capillaries 
related to their size and structure, but are much more rarely formed in endothelial cells of SC 
endothelium than in those of fenestrated endothelia. Bill and Mäepea hypothesized that I-
pores of SC develop from those minipores (Inomata et al., 1972), a scenario quite similar to 
that seen in liver sinusoids and glomerular capillaries during embryonic development 
(Bankston and Pino, 1980; Braet and Wisse, 2002; Ichimura et al., 2008).  
 
 
1.3 Plasmalemma vesicle-associated protein 
 
The only protein known so far to be localized to diaphragms of fenestral and stomatal 
diaphragms is plasmalemma vesicle-associated protein (PLVAP, synonyms: MECA32, PV-1) 
a cationic single span type II integral membrane protein which is specifically expressed in 
endothelial cells (Stan et al., 1999a, 1999b). PLVAP is encoded by Plasmalemma vesicle-
associated Protein gene in humans, but the protein has also been documented in several 
other mammalian species including mouse, rat, chicken and bovine (Stan, 2005). 
 
 
1.3.1 Ultrastructure and molecular composition of PLVAP 
 
Protein sequences and cDNA of Plvap are highly conserved across species. The monomer 
has a calculated molecular mass of about 50 KDa in the unglycosylated form and about 60 
KDa in the glycosylated form and tends to form homodimers in situ. The human PLVAP 
consists of a short N-terminal cytoplasmatic domain, a single span transmembrane domain, 
and a long C-terminal extracellular domain (Figure 4). The intracellular domain contains a 
short sequence near the transmembrane region with a putative caveolin-1 binding site (Stan, 
2005). The extracellular domain holds nine cysteines, four consensus N-glycosylation sites, a 
proline-rich region near the C-terminus, and two coiled-coil domains. The presence of the two 
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coiled-coil domains suggests the secondary structure of PLVAP to be mostly alpha helical 
(Hallmann et al., 1995; Stan et al., 1999b).  
 
 
Figure 4: Schematic drawing of the PLVAP monomer. PLVAP consists of a short N-terminal cytoplasmatic 
domain, a single span transmembrane domain, and a long extracellular C-terminal domain. The extracellular 
domain holds nine cysteines, four consensus N-glycosylation sites, a proline-rich region near the C-terminus, and 
two coiled-coil domains. TM=transmembrane domain. Cyt=cytoplasmic (modified after Stan, 2007) 
 
 
1.3.2  Localization of PLVAP and its participation in fenestrae formation 
 
PLVAP is highly expressed in lung tissue confirmed on both mRNA and protein level, but it is 
also expressed in several other vascular beds such as kidney, liver, spleen, heart and 
skeletal muscle, but at much lower levels. Within those tissues, PLVAP is exclusively found at 
stomatal diaphragms of caveolae and TECs, and fenestral diaphragms of fenestrae, as 
shown by immunolocalization of PLVAP in rat lung (Stan et al., 1999a). 
Stan and colleagues were able to show the de novo formation of stomatal diaphragms in 
caveolae and TECs, as well as fenestral diaphragms in fenestrae by upregulation of Plvap 
expression in human umbilical vein endothelial cells (HUVEC) with phorbol myristate acetate. 
Downregulation of Plvap by RNA interference resulted in the loss of diaphragms in caveolae. 
In addition, no fenestrae and transendothelial channels were observed (Stan et al., 2004). In 
turn, Ioannidou et al. found only a 70 % reduction in the amount of PLVAP in siRNA-treated 
cells. Furthermore, the partial reduction in PLVAP did not cause a significant reduction in the 
number of fenestrae. However, a population of fenestrae did not form any diaphragm and 
those fenestrae had enlarged and variable diameters and disorganized sieve plates, 
implicating that PLVAP is necessary in fenestral morphogenesis and arrangement in sieve 
plates (Ioannidou et al., 2006).  
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1.3.3 Structure of diaphragms and integration of PLVAP 
 
Based on a quick-freeze, deep-etch study from Bearer and Orci in the year 1985 (Bearer and 
Orci, 1985), Radu Stan postulated a working hypothesis for the structure of stomatal and 
fenestral diaphragms and the integration of PLVAP in diaphragms (Stan, 2007). He assumes 
that both stomatal and fenestral diaphragms are built of a scaffold of radial fibrils which are 
on one side anchored in the rim of the pore and on the other side interweave in a central 
knot, resulting in a structure similar to a spoke (Figure 5). He reckons that the fibrils consist 
of PLVAP dimers whose C termini form the central point of the diaphragm and the intense 
glycosylation near the N-terminal side of the protein (Figure 4) might help to keep the dimer 
"afloat". Furthermore, the diaphragm could be stabilized by interactions between the C 
termini of neighboring PLVAP dimers or by the cooperation of an additional stabilizing 
extracellular protein. In general, stomatal and fenestral diaphragms are very similar with 
respect to their structure, but behave differently. Studies with non-specific probes such as 
cationic molecules (Palade et al., 1981; Simionescu et al., 1984, 1982, 1981b) or lectins 
(Bankston and Milici, 1983; Bankston et al., 1991) showed that stomatal diaphragms can 
bind lectins and lack anionic sites. In contrast, fenestral diaphragms do hardly bind lectins 
(Furuya, 1990) but possess multiple anionic sites instead, which are conferred by heparan 
sulfate proteoglycans (HSPGs) (Simionescu et al., 1981c).  
 
 
Figure 5: Molecular structure of PLVAP. A, Quick-freeze, deep-etch scanning electron micrograph of a 
peritubular capillary in the rat kidney cortex presenting numerous fenestrae with fenestral diaphragms. Many 
interweaving fibrils which converge in a central point are observable. B, Working hypothesis for the integration of 
PLVAP in endothelial diaphragms. Fibrils composed of PLVAP dimers are anchored in the rim of the pore (via the 
N-terminal domain) and meet in the midpoint in a central mesh (via the C-terminal domain). The glycosylation 
sites near the N-terminal side of the protein helps to keep the dimer "afloat" by preventing the collapse on the 
plasma membrane. Picture in A is taken from Bearer and Orci, 1985. Picture in B is modified after Stan, 2007. 
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1.4 Aim of the study 
 
Since stomatal and fenestral diaphragms are thought to play a crucial role in vascular 
permeability and might be involved in pore formation in Schlemm's canal endothelium, the 
overall goal of the current study was to molecularly dissect the biological function of PLVAP. 
Specifically, the plan involved to find answers to some pivotal questions in endothelial cell 
biology. 
 What happens with stomatal and fenestral diaphragms in fenestrated endothelial cells if 
PLVAP is absent?  
 Are there any general effects on endothelial cell permeability?  
 Is there any impact on Schlemm's canal physiology? 
Furthermore, scientists recently gained some insight into the molecular composition and 
formation of caveolae (Fra et al., 1995; Stan et al., 1999a, 1999b, 1997; Vogel et al., 1998), 
whereas the precise mechanisms for the formation of TECs and fenestrae still need to be 
explored. According to a current hypothesis, fenestrae might evolve from the fusion of 
caveolae during endothelial thinning, followed by the approach of the membranes (Figure 6).  
 
 
Figure 6: Theory of fenestrae formation via fusion of caveolae. Schematic drawing of the potential onset of 
fenestrae formation. A, During endothelial thinning, caveolae could get in contact and fuse to transendothelial 
channels with two diaphragms on both sides. B, Further thinning is supposed to lead to a collapse of the 
transendothelial channel followed by the loss of one diaphragm. Modified after Kathrin Ebner, 2008. 
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Still, several findings argue against this hypothesis. For instance, caveolin-1 has been shown 
to be absent in fenestrae of glomerular endothelial cells in vivo (Sörensson et al., 2002) and 
adrenal cortical microvascular endothelial cells in culture (Esser et al., 1998b). In addition, 
neither the distribution, amount or phosphorylation of caveolin-1 is altered by VEGF (Esser et 
al., 1998b). Furthermore, the fact that fenestrations in kidney and liver endothelial cells in 
caveolin-1 knockout mice (which do not form caveolae) do not show any alterations argues 
strongly against this hypothesis (Sörensson et al., 2002; Warren et al., 2010). These data 
provoked additional questions, which were followed up in this thesis:  
 Is PLVAP involved during the process of caveolae, TEC, and fenestrae formation?  
 Is PLVAP essential for their formation? 
Due to the fact that fenestrae are bridged by diaphragms during embryonic development of 
liver sinusoids and glomerular capillaries (Bankston and Pino, 1980; Ichimura et al., 2008), I 
investigated liver sinusoidal endothelial cells in more detail. 
The general concept of my work was based on the assumption that the deletion of PLVAP 
would provide an opportunity to answer those questions based on data obtained in vivo.  
In particular, following goals were pursued: 
 
1) The generation of a knockout mouse line, resulting in a complete deletion of PLVAP 
 
2) The phenotype analysis of Plvap-deficient mice during embryonic and postnatal 
development in 2 different genetic backgrounds 
 
3) The analysis of the general expression pattern of PLVAP in fenestrated endothelial cells 
of Schlemm's canal endothelium and ocular capillaries 
 
4) The investigation of fenestrated vascular beds of Plvap-deficient animals in greater depth 
(i.e. peritubular capillaries of the kidney, capillaries of the pancreas, and Schlemm's canal 
endothelium) 
 
5) The investigation of sinusoidal endothelial cells in livers of Plvap-deficient animals
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Lack of endothelial diaphragms in fenestrae and 
caveloae of mutant Plvap-deficient mice 
 
 
(adapted from: Herrnberger L, Seitz R, Kuespert S, Bösl MR, Fuchshofer R, Tamm ER. 
 Lack of endothelial diaphragms in fenestrae and caveolae of mutant Plvap-deficient 
mice. Histochem Cell Biol. 2012, 138(5):709-724) 
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2 Lack of endothelial diaphragms in fenestrae and caveloae of 
mutant Plvap-deficient mice 
 
2.1 Abstract 
 
Plasmalemma vesicle-associated protein (PLVAP, PV-1) is specifically expressed in 
endothelial cells in which it localizes to diaphragms of fenestrae, caveolae, and 
transendothelial channels. To learn more about its function, we generated mutant mice that 
lack PLVAP. In a C57BL/6N genetic background, homozygous Plvap-deficient embryos die 
before birth and suffer from subcutaneous edema, hemorrhages, and defects in the vascular 
wall of subcutaneous capillaries. In addition, hearts of Plvap -/- embryos show ventricular 
septal defects and thinner ventricular walls. In wild-type embryos, PLVAP and caveolae with 
a stomatal diaphragm are present in endothelial cells of subcutaneous capillaries and 
endocardium, while a diaphragm is missing in caveolae of Plvap -/- littermates.  
Plvap -/- mice in a mixed C57BL/6N/FVB-N genetic background are born and survive at the 
most for 4 weeks. Capillaries of exocrine and endocrine pancreas and kidney peritubular 
interstitium were investigated in more detail as examples of fenestrated capillaries. In these 
vascular beds, Plvap -/- mice show a complete absence of diaphragms in fenestrae, 
caveloae, and transendothelial channels, findings which are associated with a substantial 
decrease in the number of endothelial fenestrae. The changes in the capillary phenotype 
correlate with a considerable retardation of postnatal growth and anemia. Plvap -/- mice 
provide an animal model to clarify the specific functional role of endothelial fenestrae and 
their contribution to passage of water and solutes in different organs. 
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2.2  Introduction 
 
The inner surface of blood vessels and lymphatics are lined by endothelial cells which 
critically contribute to the various physiological requirements of circulation. Since the different 
vascular beds vary considerably with respect to their specific functions, vascular endothelial 
cells are remarkably heterogeneous with regard to their structural and functional properties, 
and their expression pattern of characteristic molecules (Aird, 2007a, 2007b). Endothelial cell 
heterogeneity is especially evident in capillaries in which different needs for permeability of 
water and solutes require different structural phenotypes of endothelial cells. As a 
consequence, capillary endothelia may be of a discontinuous, fenestrated, or continuous 
type (Tse and Stan, 2010). Discontinuous capillary endothelial cells such as in the sinusoids 
of the liver form large circular pores that are 100-200 nm in diameter. Such openings are 
missing in continuous endothelial cells which are commonly found in capillaries of the brain, 
skin, heart, and lung. In contrast, fenestrated endothelia are observed in capillaries of 
exocrine and endocrine glands, intestinal villi, peritubular interstitium of the kidney, or the 
choriocapillaris in the eye, all organs or tissues that have in common the need for a 
substantial filtration and transendothelial transport. 
 
The structural hallmarks of endothelial cells in fenestrated capillaries are transcellular pores 
or fenestrae with a remarkably constant diameter of 62-68 nm, which extend through the full 
thickness of the endothelial cell. Fenestrae are characteristically bridged across their opening 
by a thin 5-6 nm non-membranous diaphragm (Clementi and Palade, 1969a; Friederici, 
1969, 1968a). Results from quick-freeze deep-etch electron microscopy suggest that the 
diaphragm consists of radial fibrils which extend from the peripheral rim of the cellular pore to 
meet and interweave in a central mesh (Bearer and Orci, 1985). It has been suggested that 
the presence of a diaphragm may provide fenestrae with increased size and charge 
selectivity allowing only small molecules and limited amounts of plasma protein to pass (Aird, 
2007a; Palade et al., 1981; Simionescu et al., 1981b, 1981c). 
 
Up until now, the only protein that has been found to be directly localized to fenestral 
diaphragms is plasmalemma vesicle-associated protein (PLVAP, synonyms: MECA32, PV-1), 
a cationic, integral membrane glycoprotein that is specifically expressed in endothelial cells 
(Stan et al., 1999a, 1999b). In addition to its presence in diaphragms of endothelial 
fenestrae, PLVAP was also found to be localized in the stomatal diaphragms of caveolae and 
the diaphragms of transendothelial channels (Stan, 2005; Stan et al., 2004). Moreover, in 
vitro studies in cultured cells have shown that the knock-down of Plvap expression by RNA 
interference impairs the formation of diaphragms in fenestrae, caveolae, and transendothelial 
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channels (Ioannidou et al., 2006; Stan et al., 2004). Caveolae which are defined as spherical 
invaginations of the plasma membrane of regular shape and size (about 70 nm) occur in all 
types of endothelia as well as in most vertebrate cell types. Still, caveolae with stomatal 
diaphragms are only found in some selected endothelia of the continuous type (i.e., in the 
capillaries of the lung) and in all fenestrated and sinusoidal endothelia (Bruns and Palade, 
1968; Stan, 2005). The stomatal diaphragm of caveolae appears to be quite comparable in 
structure to the diaphragms of fenestrae (Bearer and Orci, 1985). Transendothelial channels 
are pores through the entire endothelial cell provided with two diaphragms, one luminal and 
one abluminal, which are found predominantly in fenestrated endothelia (Milici et al., 1985). It 
has been hypothesized that caveolae with stomatal diaphragms fuse from luminal and 
abluminal sides of endothelial cells to form transendothelial channels which may then 
collapse to form fenestrae (Roberts and Palade, 2000). Still, the observation that in mutant 
caveolin-1-deficient mice, which do not form endothelial caveolae (Drab et al., 2001; Razani 
et al., 2001), the number of diaphragmed fenestrae and transendothelial channels is largely 
unchanged (Tkachenko et al., 2012; Zhao et al., 2002) argues against this hypothesis and 
leaves the functional role of the stomatal diaphragm in caveolae unresolved. 
 
In order to shed light on the in vivo function of PLVAP and its role in the formation of 
diaphragms in fenestrae, caveolae, and transendothelial channels, we generated mutant 
mice that lack PLVAP. We show that in the living organism such diaphragms do not form in 
the absence of PLVAP. Depending on the genetic background, the lack of diaphragms 
interferes with cardiac morphogenesis, the integrity of embryonic vessels, and the formation 
of fenestrated endothelial layers. Our mouse model will provide an ideal tool to study the in 
vivo functional properties of diaphragms in capillary endothelial cells. 
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2.3 Materials and methods 
 
2.3.1 Generation of Plvap-deficient mice 
 
Embryonic stem cell clones (HEPD0550_4_E12) were obtained through the International 
Knockout Mouse Consortium (Projekt 31505) (Skarnes et al., 2011). The targeted ES cells 
were injected into C57Bl/6N blastocysts to generate chimeras. Chimeric males transmitted 
the targeted allele to their offspring. Genotyping was routinely performed by PCR analysis, 
using two upstream primers located in intron 1 of Plvap (5’-AGAGCCTTCTCTGCCAAGTG-
3’) or in the inserted targeting cassette (5’-TCTCATGCTGGACTTCTTCG-3’), and a 
downstream primer located in intron 1 downstream of the cassette (5’-
GGCTAGCCTGAGCTACAGAGG-3’) resulting in a 672 bp PCR fragment for the wild-type 
allele and a 552 bp fragment for the targeted allele. DNA was obtained from tail tips. PCR 
analysis was performed in 15 µl reaction volumes containing standard buffer, 0.1 µM of each 
primer, 1 mM dNTPs, 2.5 mM MgCl2 , 8% glycerol, 0.2 mM cresol red sodium salt (Sigma, 
Taufkirchen, Germany) and 0.25 U Taq-Polymerase (New England Biolabs, Taufkirchen, 
Germany). The cycling conditions consisted of an initial 3-min denaturing step at 94°C, 
followed by 34 cycles for 30 s at 94°C, for 1 min at 65°C, and for 1 min 15 s at 72°C.  
Tg (TIE2GFP) 287Sato/J mice (Stock number 003658) (Motoike et al., 2000) were obtained 
from The Jackson Laboratory (Bar Harbor, Maine). Genotyping was routinely performed by 
PCR analysis, using a forward primer (5’-ATTCTCGTGGAACTGGATGG-3’) and a reverse 
primer (5’-GGACAGGTAATGGTTGTCTGG-3’), resulting in a 567bp fragment. DNA was 
obtained from tail tips. PCR was performed in 15 µl reaction volumes containing standard 
buffer, 0.1 µM of each primer, 1 mM dNTPs, 2.5 mM MgCl2 , 20% glycerol, 0.2 mM cresol red 
sodium salt (Sigma) and 0.25 U Taq-Polymerase (New England Biolabs). The cycling 
conditions consisted of an initial 3 min denaturing step at 94°C, followed by 31 cycles for 30 s 
at 94°C, for 1 min at 60°C, and for 1 min at 72°C. 
 
 
2.3.2 RNA analysis 
 
Total RNA from embryos at embryonal (E) day 13.5 or postnatal (P) day 13 was extracted 
with peqGold Trifast (Peqlab, Erlangen, Germany) according to manufacturer`s instructions. 
First strand cDNA from total RNA was generated using the iScript cDNA Synthesis Kit 
(BioRad, München, Germany) according to the manufacturer`s recommendations. RNA that 
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was not reverse transcribed into cDNA served as negative control for real-time RT-PCR. 
Real-time RT-PCR was performed on a BioRad iQ5 Real-time PCR Detection System 
(BioRad) with the temperature profile as follows: 40 cycles of 10 s melting at 95°C and 40 s 
of annealing and extension at 60°C. Primer pairs (Table 1) were purchased from Invitrogen 
(Darmstadt, Germany) and were designed to extend over exon-intron boundaries. In initial 
experiments, the potential housekeeping genes for real-time RT-PCR were identified for each 
tissue and best results were obtained for GAPDH for whole embryos at E13.5 and GNB2L for 
mouse tissue (P13). Quantification was performed using BioRad iQ5 Standard-Edition 
(Version 2.0.148.60623) software (BioRad). 
 
Primer Sequence 
mPlvap fwd 5’-TCAACAAGACCTGCGAAGC-3’ 
mPlvap rev 5’-AGCACACTGCCTTCTCCTTG-3’ 
mGNB2L fwd 5’-TCTGCAAGTACACGGTCCAG-3’ 
mGNB2L rev 5’-GAGACGATGATAGGGTTGCTG-3’ 
mGAPDH fwd 5’-TGTCCGTCGTGGATCTGAC-3’ 
mGAPDH rev 5’-CCTGCTTCACCACCTTCTTG-3 
Table 1. Primer used for real-time RT-PCR 
 
 
2.3.3 Western blot analysis 
 
Tissues were homogenized in RIPA buffer (150 mM NaCl, 1% NP-40, 0.5% deoxycholic acid, 
0.1% SDS, and 50 mM Tris), and insoluble constituents were removed by centrifugation. For 
Western blot analysis of PLVAP up to 30 µg of protein was subjected to an 8% SDS-PAGE 
and transferred onto a PVDF membrane (Roche Diagnostics GmbH, Mannheim, Germany) 
by semidry blotting. After blocking with 5% low-fat milk in TBS-T, membranes were incubated 
overnight with rat anti-mouse pan ECA (MECA-32) IgG2a antibodies (Santa Cruz 
Biotechnology, Santa Cruz, CA), diluted 1:500 in 0.5 % low-fat milk in TBS-T. After washing in 
TBS-T, membranes were hybridized with HRP-conjugated chicken anti-rat antibodies 
(SantaCruz), diluted 1:1000 in 0.5% low-fat milk in TBS-T. For visualization, membranes 
were incubated in Luminata Forte Western HRP Substrate (Millipore Corporation, Billerica, 
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MA) and visualized on a LAS 3000 Imager work station (Fujifilm, Düsseldorf, Germany). As 
loading control membranes were stained with Coomassie Blue. 
 
 
2.3.4 Light microscopy 
 
Embryos were obtained from timed mating with noon of the day of vaginal plug discovery 
designated as 0.5 days of gestation (E 0.5). Embryos and tissues were collected, rinsed in 
PBS and fixed in 4 % PFA for 4 h. After washing in 0.1 M phosphate buffer the tissue 
samples were processed through several graded alcohols and xylenes, and embedded in 
paraffin. Sections were stained with hematoxylin and eosin (H and E) and analyzed using a 
Zeiss Axio Imager microscope (Carl Zeiss AG, Oberkochen, Germany). Blood smears were 
generated with blood collected from tail veins. The slides were fixed in 100% methanol for 10 
min, washed in H2O and stained with 300 µl May-Grünwald-Giemsa solution (Fluka Chemika, 
Buchs, Switzerland) in 10 ml H2O. For Immunohistochemistry, embryos and tissue samples 
were fixed in Carnoy’s fixative (60 % methanol, 30 % chloroform, and 10 % acetic acid) for 4 
h, washed in 0.1 M phosphate buffer and embedded in paraffin. For frozen sections, the 
tissue was equilibrated in 10, 20, and 30 % sucrose for 4 h and embedded in Tissue-Tek 
optimal cooling temperature (OCT) compound (Sakura Finetek Europe B.V., Zoeterwoude, 
NL) and cooled at -20 °C. After removal of Tissue-Tek and paraffin, the sections were 
blocked with 0.2 % cold water fish gelatin (Aurion, Wageningen, Netherlands), 1 % BSA and 
0.1 % Triton-X (all in 0.1 M PBS) for 1 h at room temperature. After blocking, the sections 
were incubated with anti-pan ECA (MECA-32) IgG2a (1:50, Santa Cruz) and anti-
CD31/PECAM-1 IgG (1:20, R&D Systems, Wiesbaden, Germany) for double labeling. Alexa 
Fluor 488 (1:1000) rabbit anti-goat IgG (Invitrogen) and donkey anti-rat IgG (1:2000) 
conjugated to Cy3 (Jackson Immuno Research) were used as secondary antibodies and 
incubated for 1 h at room temperature. 4′,6-Diamidino-2-phenylindole (DAPI) was used to 
counterstain nuclear DNA. Slides were mounted in a medium containing DAPI (Vectashield; 
Vector Laboratories, Burlington, CA, USA) and analyzed under a fluorescence microscope 
(Zeiss Axio Imager). For negative controls, primary antibodies were omitted and the slides 
were incubated with secondary antibodies only. 
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2.3.5 Transmission electron microscopy 
 
Tissue samples were fixed in 2.5 % glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4) for 4 
h. Samples were washed, postfixed with 1 % OsO4, 0.8 % K4[Fe(CN)6] in 0.1 M cacodylate 
buffer for 1.5 h, dehydrated with graded ethanol solutions and embedded in Epon (Roth, 
Karlsruhe, Germany). Semithin sections were stained with Richardson’ stain (Richardson et 
al., 2009). Ultrathin sections were stained with uranyl acetate and lead citrate, and analyzed 
on a transmission electron microscope (Libra, Zeiss). 
 
 
2.3.6 Staining for β-galactosidase activity 
 
Embryos and tissues were fixed in 2.5 % glutaraldehyde in 5 mM EGTA (pH 7.3) and 2 mM 
MgCl2 dissolved in 0.1 M PBS for 4 h on ice with shaking. After three 30 min rinses in 
washing buffer (2 mM MgCl2, 0.01 % sodium deoxycholate, 0.02 % Nonidet-P40 in 0.1 M 
PBS), β-galactosidase activity was visualized in X-Gal staining solution (0.1 M PBS, 2 mM 
MgCl2, 0.01 % sodium deoxycholate, 0.02 % Nonidet-P40, 5 mM potassium ferrocyanide, 5 
mM potassium ferricyanide, 1 mg/ml X-Gal). Tissues were stained for 24 h at 37 °C in the 
dark, washed 3 times for 5 min in washing buffer and embedded in paraffin or in Tissue-Tek 
for frozen sections. 
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2.4 Results 
 
2.4.1 Targeted removal of Plvap leads to embryonic death 
 
To disrupt gene function, an IRES:lacZ trapping cassette and a promoter-driven neo cassette 
(Skarnes et al., 2011) were inserted between exons 1 and 2 of Plvap (Figure 7A). Following 
germ-line transmission, genotyping of newborn pups was performed by PCR. In the 
C57BL/6N genetic background that was used for initial breeding, only heterozygous Plvap-
deficient mice or wild-type littermates were detected, strongly indicating that the complete 
deletion of Plvap is lethal during prenatal development. Next, heterozygous Plvap-deficient 
mice were crossed with each other to obtain embryos for genotyping. We were now able to 
detect homozygous Plvap-deficient embryos in addition to embryos with Plvap +/- or wild-type 
genotype when litters at embryonic (E) days E 13.5 to E 17.5 were analyzed (Figure 7B). By 
real-time RT-PCR, we observed in Plvap +/- embryos a reduction of approximately 50% in the 
amount of Plvap mRNA when compared with wild-type littermates, while no mRNA was 
detected in Plvap -/- embryos (Figure 7C).  
 
 
Figure 7: Generation of mutant Plvap-deficient mice. A, Schematic representation of the targeted allele. B, 
Genotyping by PCR using a template DNA from embryos following mating of heterozygous Plvap-deficient mice. 
A 552-bp fragment illustrates the presence of the mutated allele which replaces the wild-type locus normally 
represented as a 672-bp fragment. C, Real-time RT-PCR analysis for Plvap mRNA in total RNA from whole 
embryos at E 13.5. The mean value obtained with RNA from wild-type embryos was set to 1. GAPDH was used 
as a reference gene.  
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Lack of PLVAP was further confirmed by immunohistochemistry. In E 16.5 wild-type embryos, 
double immunohistochemistry with antibodies against PLVAP and the endothelial cell marker 
CD31 showed the presence of PLVAP in capillary endothelial cells of small intestine (Figure 
8A) and lung (Figure 8B). In contrast, no labeling for PLVAP was observed in small intestine 
and lung of Plvap -/- littermates (Figure 8A, B). 
 
 
Figure 8: Generation of mutant Plvap-deficient mice. A and B, Double immunohistochemistry with antibodies 
against PLVAP and the endothelial cell marker CD31 shows the presence of PLVAP in capillary endothelial cells 
of small intestine (A) or lung (B) in E 16.5 wild-type animals, but not in Plvap 
-/-
 littermates.  
 
 
2.4.2 Plvap-deficient embryos suffer from subcutaneous edemas and hemorrhages 
 
E 16.5 Plvap -/- embryos were typically presented with a pronounced subcutaneous edema 
that extended from the neck to the lower back (Figure 9A, B). In addition, focal hemorrhages 
were present in various subcutaneous regions of trunk, extremities, head, and neck (Figure 
9A, B). In areas not affected by subcutaneous hemorrhages, the skin was quite pale when 
compared with that of wild-type littermates indicating anemia (Figure 9A). Moreover, blood 
filled intact vessels that shined through the skin of body or umbilical cord in wild-type animals 
were not visible in Plvap -/- embryos (Figure 9A). Neither subcutaneous edemas nor 
hemorrhages were observed in wild-type littermates (Figure 9A). At E 17.5, homozygous 
Plvap-deficient embryos suffered from severe total body edema and extensive non-specific 
focal hemorrhages (Figure 9A, B). While homozygous Plvap-deficient embryos were still 
viable at E 17.5 as evidenced by cardiac pulsation and spontaneous movements, no Plvap -/- 
embryos were observed to be alive at later stages.  
 
Chapter 2  32 
 
 
Figure 9: Phenotype of Plvap-deficient embryos in C57BL/6N background. A, E 16.5 Plvap 
-/-
 embryo with a 
pronounced subcutaneous edema that extends from the neck to the lower back (white arrow). In addition, focal 
hemorrhages are present in various subcutaneous regions of trunk, extremities, head, and neck (black arrows). In 
areas not affected by subcutaneous hemorrhages, the skin is pale when compared with that of the wild-type 
littermate. In addition, blood-filled intact vessels that shine through the skin of the body or umbilical cord in the 
wild-type animal are not visible in the Plvap 
-/-
 embryo. Neither subcutaneous edema nor hemorrhages are seen in 
the wild-type embryo. The E 17.5 Plvap 
-/-
 embryo shows severe total body edema and extensive non-specific 
focal hemorrhages (black arrows). B, Higher magnification of edema in the dorsal region of an E 16.5 Plvap 
-/-
 
embryo (white arrows) and of subcutaneous hemorrhages (black arrows).  
 
 
Subcutaneous edemas and hemorrhages were similarly detected in horizontal sections 
through E 16.5 Plvap -/- embryos, which showed accumulations of extracellular erythrocytes 
as well as a marked widening of the extracellular spaces beneath the skin in the anterior and 
dorsal regions of the trunk (Figure 10A-C). In contrast, neither subcutaneous edemas nor 
hemorrhages were observed in wild-type littermates (Figure 10A-C).  
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Figure 10: Histological characterization of Plvap-deficient embryos in C57BL/6N background.  A, 
Transversal paraffin sections through the thorax of E 16.5 embryos stained with H and E. The Plvap 
-/-
 embryo 
displays edema in the anterior region of the trunk (black arrow) and hemorrhages (white arrow) beneath the skin, 
which are not seen in the wild-type littermate. B and C, Higher magnification of boxed areas in A. B, In the Plvap 
-
/-
 embryo, but not in the wild-type littermate, numerous erythrocytes (white arrows) can be seen outside of 
capillaries in the surrounding tissue, indicating open blood vessels (black arrow). C, Massive widening of the 
extracellular spaces indicating subcutaneous edema in the Plvap-deficient (black arrows). Sc spinal cord, Lu lung, 
He heart, St sternum.  
 
To follow up on the question, if lack of PLVAP in subcutaneous blood vessels might be 
responsible for subcutaneous edemas and hemorrhages, we analyzed the expression and 
the localization of PLVAP in this region.  
When staining for β-galactosidase was performed at E 15.5 to detect expression of the 
reporter gene lacZ and activity of the Plvap promoter, positive staining was observed in 
endothelial cells of subcutaneous capillaries in Plvap-deficient embryos, but was absent 
throughout the entire subcutaneous region of wild-type littermates (Figure 11A). 
Subsequently, we performed immunostaining with antibodies against PLVAP and the 
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endothelial cell marker CD31 to find immunoreactivity for PLVAP in endothelial cells of the 
vast majority of mouse subcutaneous capillaries at E 16.5 (Figure 11B). In contrast, no 
specific immunoreactivity for PLVAP was observed in homozygous Plvap-deficient embryos 
(Figure 11B). Finally, we investigated endothelial cells of subcutaneous capillaries at E 17.5 
by transmission electron microscopy. In both wild-type and Plvap-deficient embryos, the 
endothelium of subcutaneous capillaries was continuous without fenestrae (Figure 11C). 
Upon higher magnification, endothelial cells of wild-type capillaries showed numerous 
caveolae with stomatal diaphragms on both their luminal and abluminal surfaces. 
Accordingly, the neck or stroma of the caveolae was bridged by a distinct, 5- to 7-nm thick, 
electron-dense diaphragm (Figure 11C). Caveolae with stomatal diaphragms were invariably 
absent in capillaries of Plvap -/- embryos. Here, the neck of caveolae was not bridged by a 
diaphragm, but contained some ill-defined, fluffy electron-dense material instead (Figure 
11C).  
 
 
Figure 11: Expression and localization of PLVAP.  A, β-galactosidase staining of sagittal frozen sections 
through the back skin and adjacent subcutaneous tissue of a wild-type embryo and a Plvap 
-/- 
littermate at E 15.5. 
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Positive staining (arrows) is seen in the endothelial cells of subcutaneous capillaries in the Plvap 
-/-
 embryo, 
whereas no staining is detectable in the wild-type littermate. B, Double labeling of transverse paraffin sections 
through the back skin and adjacent subcutaneous tissue of an E 16.5 wild-type embryo with antibodies against 
PLVAP (red) and CD31 (green) shows immunoreactivity for PLVAP in the majority of subcutaneous capillaries 
(arrows) and largely colocalizes with CD31 as seen in the merged picture. No specific staining for PLVAP is 
observed in the Plvap-deficient embryo. C, Transmission electron microscopy of subcutaneous capillaries at E 
17.5. Both wild-type and Plvap 
-/-
 subcutaneous capillaries exhibit a continuous endothelium without fenestrae 
(arrows). At higher magnification, wild-type endothelial cells show numerous caveolae with a distinct 5- to 7-nm 
thick stomatal diaphragm (arrows). Caveolae are not bridged by a diaphragm in the endothelial cell membrane of 
the Plvap 
-/-
 embryo, but contain fluffy electron-dense material instead (arrows).  
 
When areas with subcutaneous hemorrhages were more closely investigated, capillaries 
were observed in which the endothelial wall appeared to be incomplete (Figure 12A). 
Transmission electron microscopy confirmed the lack of endothelial integrity and revealed 
extensive defects in the endothelial lining of capillaries. In places, the defects were bridged 
by degranulated thrombocytes (Figure 12B, C). 
 
 
Figure 12: Loss of endothelial integrity in Plvap 
-/-
 embryos.  A, Semithin section (Richardson's stain) through 
an area with subcutaneous hemorrhage in an E 16.5 Plvap 
-/-
 embryo. Erythrocytes are seen within and outside a 
capillary with a fragmented wall that contains large openings (arrows). B and C, Transmission electron 
microscopy of a capillary with a large opening (arrows) that is bridged by processes of degranulated thrombocytes 
(Tr). C, Higher magnification of B.  
 
 
2.4.3 Cardiac defects in Plvap -/- embryos 
 
Since total body edema and extensive hemorrhages in mouse embryos are very often 
associated with defects in cardiac morphogenesis (Clark et al., 1999; Dumont et al., 1994; 
Nasser et al., 2008; Patan, 1998; Peng et al., 2008; Puri et al., 1995; Ranger et al., 1998; 
Sato et al., 1995; Wu et al., 2000), we next investigated the hearts of Plvap -/- embryos and of 
their wild-type littermates. E 16.5 embryos were cut in the transverse plane and examined in 
serial sections from the cephalic to the caudal aspects of the specimens. In each of the three 
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Plvap -/- embryos that were investigated, histological serial sections stained with H and E 
showed a distinct muscular ventricular septal defect (Figure 13A). In the affected embryos, 
the cardiac ventricular walls were also thinner than those of the wild-type embryos (Figure 
13A). By immunohistochemistry, specific immunoreactivity for PLVAP was observed in the 
endocardium of wild-type mice, but not in that of Plvap -/- embryos (Figure 13A). Moreover, 
the endocardium of cardiac ventricle and atrium as well as the endothelial cells of the 
associated cardiac vessels were stained for β-galactosidase indicating activity of the Plvap 
promoter (Figure 13B). 
 
 
Figure 13: Cardiac and blood abnormalities in Plvap 
-/-
 embryos.  A, H and E stained transverse paraffin 
sections through the thorax of wild-type and Plvap 
-/-
 embryos at E 16.5. The heart (He) of the Plvap 
-/-
 embryo 
shows a muscular ventricular septal defect (black arrows) and a thinner ventricular wall (white arrow) when 
compared with the wild-type control. Immunohistochemistry for PLVAP (red) shows positiv immuoreactivity in the 
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ventricular endocardium of the wild-type heart (white arrows), but not in that of the Plvap 
-/-
 embryo. Nuclear DNA 
is labeled with DAPI (blue). B, β-galactosidase staining in an E 15.5 Plvap 
-/-
 embryo shows activity of the Plvap 
promoter in ventricular and atrial endocardium, and in the endothelium of associated cardiac vessels. C, Smears 
of blood (May-Grünwald-Giemsa stain) collected from tail veins at E 16.5 show more nucleated red blood cells 
from the Plvap 
-/-
 embryo compared with the wild-type littermate. D, Ratio of nucleated erythrocytes to enucleated 
erythrocytes at different embryonic stages (E 14.5, E 16.5, E 17.5). SC spinal cord, Lu Lung.  
 
 
Finally, we investigated the percentage of nucleated erythrocytes in blood smears from 
embryonic blood (Figure 13C), as we had observed in Plvap -/- embryos multiple nucleated 
erythrocytes in tissue sections of hemorrhages (Figure 10B, Figure 12A). In the blood smear 
of an E 14.5 wild-type embryo, 21 % of erythrocytes were found to be nucleated, a number 
that dropped to 1 % in an E 16.5 embryo, while essentially no nucleated erythrocytes were 
observed at E 17.5. In contrast, in Plvap -/- embryos, 61 % of erythrocytes were nucleated at 
E 14.5, 11 % at E 16.5 and still 2 % at E 17.5 (Figure 13D). 
 
 
2.4.4 Plvap -/- mice in a mixed C57BL/6N/FVB-N background are viable and do not 
form fenestrae with diaphragm 
 
In the course of our studies, we crossed Plvap-deficient mice that had been bred in a 
C57BL/6N genetic background with TIE2GFP mice that are in a FVB-N genetic background. 
While the initial goal was to take advantage of the GFP-labeling in endothelial cells of 
TIE2GFP mice, we observed that in the mixed C57BL/6N/FVB-N background, Plvap -/- 
animals are viable after birth and survive at the most up to an age of 4 weeks. E 17.5 
embryos in the mixed background showed edema in the neck and back, but no visible 
hemorrhages (Figure 14A). 
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Figure 14: Phenotype of Plvap 
-/-
 animals in mixed C57BL/6N/FVB-N background.  A, An E 17.5 Plvap 
-/-
 
embryo shows edema in neck and back (white arrow) which is not seen in the wild-type littermate. B, A 15-day-
old Plvap 
-/-
 animal with a kink in the tail (arrow) shows a marked reduction in body size when compared with its 
wild-type littermate. C, Real-time RT-PCR for Plvap mRNA in RNA from eye, pancreas, lung, and kidney of wild-
type (wt), heterozygous (+/-) and homozygous (-/-) Plvap-deficient animals at 4 weeks of age. The mean value of 
wild-type RNA was set at 1. GNB2L was used as a reference gene. D, Western blot analysis for PLVAP in 
proteins isolated from kidneys of homozygous Plvap-deficient mice and their wild-type littermate at P 13. (E, F) 
Kidney (E), spleen (black arrows, F) and pancreas (white arrows, F) are smaller in a 3-week-old Plvap 
-/-
 animal 
when compared with the wild-type littermate and were very pale indicating anemia. Experiment in C performed by 
Sabrina Küspert. Experiment in D performed by Roswitha Seitz. 
 
 
Postnatal, Plvap -/- mice show a marked reduction in body size when compared with wild-type 
littermates (Figure 14B). In addition, Plvap -/- mice typically show kinks in their tails that are 
not seen in wild-type littermates (Figure 14B). No ventricular septal defect was observed in 
tangential sections through the heart of 3-week-old mice (data not shown). When the 
expression of Plvap was analyzed by real-time RT-PCR at 4 weeks of age in organs known 
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to contain numerous capillaries with diaphragmed fenestrae and/or SD caveolae, we 
observed in eye, pancreas, lung, and kidney of Plvap +/- animals an approximately 50 % 
reduction in the amount of Plvap mRNA when compared with wild-type littermates, while no 
mRNA was detected in Plvap -/- animals (Figure 14C). Using Western blot analysis of proteins 
from kidneys of P13 Plvap +/- and wild-type embryos, three bands were observed at 55-60 
KDa consisting with the presence of glycosylated and non-glycosylated forms of PLVAP 
(Hnasko et al., 2006). PLVAP immunoreactive bands were essentially absent in Plvap -/- 
animals (Figure 14D). Subsequently, the structure of two of these organs, kidney and 
pancreas, respectively, was investigated in more detail. Both kidney (Figure 14E) and 
pancreas (Figure 14F) were smaller in Plvap -/- mice when compared with the same organ 
from wild-type littermates and were very pale indicating anemia.  
 
Immunostaining for PLVAP showed positive immunolabeling in interstitial capillaries of wild-
type kidneys which was absent in those from Plvap -/- mice (Figure 15A). Using transmission 
electron microscopy of peritubular capillary endothelial cells in wild-type animals, numerous 
fenestrae with diaphragm were observed in areas in which the endothelial lining was thin 
(Figure 15B). Fenestrae were commonly arranged in rows and between neighboring 
fenestrae there was a regular distance of about 130 nm indicating their arrangement in 
typical sieve plates (Tse and Stan, 2010). In contrast, in Plvap -/- mice, the endothelial wall of 
interstitial peritubular capillaries was considerably thicker and fenestrae were not commonly 
observed (Figure 15B). In cross sections through peritubular capillaries, a considerable 
number of capillaries did not show fenestrae at all, while in others few endothelial openings 
with a diameter of 60-80 nm were observed in some parts of the circumference (Figure 15B). 
No diaphragms were observed in the endothelial openings of Plvap -/- peritubular capillaries 
(Figure 15B). In addition, SD caveolae were observed in wild-type capillaries (Figure 15B), 
but not in that of Plvap -/- animals. 
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Figure 15: Peritubular capillaries in kidneys of Plvap-deficient animals do not form diaphragms. A, 
Immunolabeling for PLVAP (red) shows specific staining (arrows) in the peritubular capillaries of wild-type mice at 
4 weeks of age, whereas no specific immunoreactivity is seen in kidneys of Plvap 
-/-
 littermates. Nuclear DNA is 
labeled with DAPI (blue). B, Upper panels transmission electron microscopy of a 4-week-old wild-type animal 
shows thin peritubular capillary endothelial cells with numerous fenestrae that are arranged in rows. In contrast, in 
the Plvap 
-/-
 littermate, the endothelial wall of a peritubular capillary is considerably thicker and does not form 
fenestrae. B, Lower panels higher magnification shows that fenestrae are bridged by a distinct diaphragm in wild-
type capillaries (black arrows). In addition, a caveola with a stomatal diaphragm (white arrow) is seen. In contrast, 
the few endothelial openings that are formed in the Plvap 
-/-
 littermate are not bridged by a diaphragm (black 
arrows). PT proximal tubulus.  
 
 
When pancreas was investigated, the parenchymal tissue of wild-type pancreas appeared to 
contain larger interstitial spaces than that of Plvap -/- littermates (Figure 16A, B). Staining for 
β-galactosidase was observed in capillaries of both the exocrine and endocrine pancreas in 
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Plvap -/- mice, but was essentially absent in wild-type littermates (Figure 16B). Quite 
comparable to the results obtained in peritubular kidney capillaries, endothelial cells between 
acini of the wild-type exocrine pancreas were thin and contained continuous rows of 
fenestrae (Figure 16C). Upon higher magnification, the fenestrae were bridged by 
diaphragms as were caveolae and transendothelial channels with stomatal diaphragms 
(Figure 16C). In contrast, in Plvap -/- animals, the wall of capillaries in the exocrine pancreas 
was considerably thicker and was continuous over large distances without any fenestrae. 
Some capillaries were detected that contained openings in parts of their circumference with 
diameters between 60 and 80 nm (Figure 16C). The openings did not contain diaphragms, 
but were rather filled with fluffy, electron-dense material (Figure 16C). Essentially comparable 
results were obtained when capillaries from the endocrine pancreas were examined (not 
shown). 
 
 
Figure 16: Capillaries in the pancreas of Plvap-deficient animals do not form diaphragms.  A, Upper panels 
Semithin sections through the pancreas of 4-week-old animals. The wild-type control mouse shows larger 
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interstitial spaces then the Plvap-deficient littermate. A, Lower panels Positive staining for β-galactosidase is 
evident in capillaries of the exocrine and islets (Is) of endocrine pancreas in the Plvap 
-/-
 mouse, but not in that of 
the wild-type littermate. B, Upper panels Transmission electron microscopy of a wild-type capillary in the exocrine 
pancreas shows thin endothelial cells with numerous fenestrae (arrows). In contrast, in the Plvap 
-/-
 littermate, the 
endothelial lining (arrow) is considerably thicker and continuous without any fenestrae. B, Lower panels Upon 
higher magnification, the fenestrae of the wild-type animal are bridged by diaphragms (black arrows) as are 
caveolae (white arrow) and transendothelial channels (double arrow) with stomatal diaphragms. In contrast, the 
few endothelial openings that are formed in the Plvap 
-/-
 littermate are not bridged by diaphragms, but are partially 
filled with fluffy, electron-dense material (arrows). Is islet.  
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2.5 Discussion 
 
We conclude that PLVAP is essential for the formation of diaphragms which bridge 
endothelial fenestrae, or the stomata of caveolae and transendothelial channels. Moreover, 
the lack of PLVAP and/or diaphragms causes a substantial decrease in the number of 
capillary openings in vascular beds that typically form fenestrated capillaries, such as the 
peritubular interstitium of the kidney or the exocrine and endocrine pancreas. The changes in 
the capillary phenotype correlate with a considerable retardation of postnatal growth and 
anemia. Depending on the respective genetic background, lack of PLVAP and/or diaphragms 
may cause embryonic lethality due to widespread hemorrhages and cardiac malformations. 
The phenotype observed in Plvap -/- mice supports and extends data from previous 
observations of others obtained by in vitro assays. Stan and colleagues induced the 
upregulation of Plvap expression in cultured human umbilical vein endothelial cells (HUVEC) 
with phorbol myristate acetate (PMA) and observed the de novo formation of stomatal 
diaphragms in caveolae and transendothelial channels, as well as of fenestrae upon 
treatment (Stan et al., 2004). After applying RNA interference, none of the caveolae in 
siRNA-treated cells had a stomatal diaphragm present. In addition, no fenestrae or 
transendothelial channels were observed. Ioannidou and coworkers (Ioannidou et al., 2006) 
used the actin depolymerizing agent latrunculin A to induce fenestrae in the bEND5 mouse 
endothelioma cell line. By siRNA treatment, a 70 % reduction in the amounts of PLVAP was 
observed. The partial reduction in PLVAP did not cause a significant reduction in the amounts 
of fenestrae. Still, following treatment, a population of fenestrae did not form diaphragms. 
Fenestrae devoid of diaphragms had enlarged and variable diameters, whereas fenestrae 
that displayed regular or smaller-than-usual diameters contained diaphragms. 
 
Clearly, our data obtained with transmission electron microscopy, showing a complete 
absence of diaphragms in fenestrae, caveolae, and transendothelial channels in Plvap -/- 
mice, strongly suggest that PLVAP is an integral molecular component of diaphragms that is 
critically required for their formation. Similar to the data obtained by an in vitro knock-down of 
Plvap (Stan et al., 2004), we did not observe an obvious reduction in the number of caveolae 
in endothelial cells of Plvap -/- mice. However, we did observe a substantial reduction in the 
number of fenestrations or endothelial openings in the two vascular beds that were 
investigated in detail, namely the exocrine and endocrine pancreas, and the peritubular 
interstitium of the kidney. In normal mice, basically all fenestrations of both these vascular 
beds are bridged by a diaphragm (Milici et al., 1985). Upon Plvap deficiency in vivo, the 
formation of endothelial openings is severely impaired, though not completely abolished, 
since some openings without diaphragm are still present. It is of interest to note that the few 
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endothelial openings in Plvap -/- mice usually appear not to be completely empty, but rather 
contain some fluffy electron-dense material indicating the presence of some molecules other 
than PLVAP. Possible candidates could be heparin sulfate proteoglycans that have been 
detected on the luminal surfaces of fenestrae providing distinct anionic charges (Simionescu 
et al., 1981b, 1981c). It appears to be more than likely that the substantial decrease in the 
number of endothelial fenestrae should cause a considerable reduction in transendothelial 
passage of water and solutes in the vascular beds affected. The almost complete absence of 
interstitial spaces in the pancreas of Plvap -/- mice is consistent with this assumption. Also the 
considerable decrease in body size of Plvap -/- animals could be the result of a functional 
impairment in the numerous organs that require fenestrated capillaries for normal function. 
 
Another interesting aspect of our study is the fact that the phenotype observed upon Plvap 
deficiency critically depends on the respective genetic background. While Plvap -/- mice in a 
mixed C57BL/6N/FVB-N genetic background are born and survive for at least 4 weeks, a 
pure C57/BL/6N background results in embryonic lethality. Likely reasons for the lethal 
phenotype are widespread hemorrhages and failures in cardiac morphogenesis. The only 
endothelial structures with a diaphragm in the subcutaneous vessel that appear to be 
primarily affected by hemorrhages are caveolae with a stomatal diaphragm. Stomatal 
diaphragms may provide a mechanical stabilization for embryonic capillaries especially 
during the morphogenetic events during angiogenesis that require remodeling of capillary 
walls. Lack of diaphragms upon Plvap deficiency may increase the risk of breaks in the 
endothelial lining and cause hemorrhages. An alternative explanation could be related to the 
fact that caveolae are required for the proper organization of signaling pathways within 
endothelial cells by providing membrane domains for preformed signaling complexes (Frank 
et al., 2003b; Stan, 2005). Such signaling pathways might function in both angiogenesis and 
heart morphogenesis. As caveolin 1-deficient mice that form no caveolae in endothelial cells 
do not die during embryonic development (Drab et al., 2001; Razani et al., 2001), such a 
function in a signaling pathway should be specific for caveolae with stomatal diaphragms and 
should still be transferred by PLVAP even in the absence of caveolae. Recent studies that 
show rapid internalization and degradation of PLVAP in the absence of caveolae in 
caveolin 1-deficient mice argues against this hypothesis (Tkachenko et al., 2012).  
 
An explanation for the higher number of primitive nucleated erythrocytes in Plvap-deficient 
embryos may be the higher need for oxygen carriers in the presence of multiple 
hemorrhages. In the mouse embryo, erythrocyte formation occurs at around E 8 in the yolk 
sac blood islands and results a day later in the release of primitive nucleated erythrocytes 
into the circulation (Brotherton et al., 1979). The nucleated cells persist in circulation until 
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about E 16 when they are finally replaced by mature erythrocytes originating from the liver 
which becomes the principal fetal hematopoietic organ (Keller et al., 1999).  
 
In summary, functional analyses of Plvap -/- mice should help to clarify the specific role of 
endothelial fenestrae and their contribution to passage of water and solutes, and the relative 
importance of transcellular versus paracellular flow in different organs. In addition, they are 
expected to provide an animal model to clarify the specific function of stomatal diaphragms. 
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The role of plasmalemma vesicle-associated 
protein (PLVAP) in endothelial cells of Schlemm's 
canal and ocular capillaries 
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3 The role of plasmalemma vesicle-associated protein 
(PLVAP) in endothelial cells of Schlemm's canal and ocular 
capillaries 
 
3.1 Abstract 
 
Plasmalemma vesicle-associated protein (PLVAP, PV-1) is an endothelial protein that 
specifically localizes to diaphragms of fenestrae in fenestrated capillaries, and to stomatal 
diaphragms of caveolae. Here we investigated the localization of PLVAP in Schlemm's canal 
endothelium and ocular capillaries, and studied the structural effects of PLVAP deficiency. In 
mouse, pig, and human eyes, immunoreactivity for PLVAP was present in fenestrated 
capillaries of choroid and ciliary processes, but not in the continuous capillaries of the retina 
and ciliary muscle. In all three species staining for PLVAP was seen in the endothelia of the 
outflow vessels of aqueous humor e.g. Schlemm's canal (SC, mouse and human), aqueous 
plexus (AP, pig) and the scleral collector channels. Essentially comparable findings were 
observed when the expression of β-galactosidase was investigated in mutant heterozygous 
and homozygous Plvap-deficient mice with LacZ inserted into the Plvap locus. By 
transmission electron microscopy, the vast majority of caveolae in SC endothelial cells 
showed a stomatal diaphragm. In addition, solitary fenestrae or minipores with a diaphragm 
were occasionally observed in SC or AP of all three species. In contrast, mutant Plvap -/- mice 
showed a complete absence of stomatal diaphragms in SC caveolae while no SC minipores 
were observed. Moreover, diaphragms were absent in fenestrae of endothelial cells in the 
capillaries of the ciliary processes or the choriocapillaris, findings which were associated with 
a substantial decrease in the number of fenestrae. PLVAP is expressed in endothelial cells of 
Schlemm's canal and is essential for the formation of diaphragms in vascular endothelial cell 
of the eye. 
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3.2 Introduction 
 
The structure of capillary endothelial cells is markedly dissimilar in the different vascular beds 
of the body (Tse and Stan, 2010). Depending on the respective needs for permeability of 
water and solutes, capillaries are of the discontinuous, continuous or fenestrated type. 
Discontinuous capillaries such as the sinusoids of the liver or the glomerular capillaries of the 
kidney form large, 100-200 nm wide, intracellular pores throughout their endothelial walls. 
Such pores are absent in the continuous capillaries of retina, brain, lung or skin. Fenestrated 
endothelia are present in capillaries with need for substantial filtration and transendothelial 
transport such as in ciliary processes and choriocapillaris of the eye, exocrine or endocrine 
glands, intestinal villi, or peritubular interstitium of the kidney. The characteristic hallmark of 
fenestrated capillaries is the presence of small transendothelial pores or fenestrae with a 
constant diameter of 62-68 nm, which extend through the full thickness of the endothelial 
cell. Fenestrae are bridged across their opening by a thin 5-6 nm non-membranous 
diaphragm (Clementi and Palade, 1969c; Friederici, 1969, 1968b). The presence of a 
diaphragm with associated basal lamina and glycocalyx may provide fenestrae with 
increased size and charge selectivity allowing only small molecules and limited amounts of 
plasma protein to pass (Levick and Smaje, 1987; Simionescu et al., 1981a, 1981b, 1981c). 
Accordingly, diaphragms are absent in the large pores of liver sinusoids or glomerular 
capillaries with substantially higher hydraulic conductivity than that of fenestrated capillaries 
(Renkin, 1977). Still, during development, liver sinusoids and glomerular capillaries first form 
fenestrae subtended by a diaphragm, which precede sinusoidal and glomerular pores 
(Bankston and Pino, 1980, 1980; Reeves et al., 1980). 
 
So far, the only protein that has been identified as being part of fenestral diaphragms is 
plasmalemma vesicle-associated protein (PLVAP, PV-1), a cationic, integral membrane 
glycoprotein that is specifically expressed in endothelial cells. In addition, PLVAP is present 
in the stomatal diaphragms of caveolae and the diaphragms of transendothelial channels 
(Stan, 2005; Stan et al., 1999b). Caveolae with a stomatal diaphragm quite comparable in 
structure to the diaphragm of fenestrae (Bearer and Orci, 1985) are found in all fenestrated 
and sinusoidal endothelia (Bruns and Palade, 1968; Stan, 2005). Transendothelial channels 
are pores provided with two diaphragms, one luminal and one abluminal, which are 
predominately found in fenestrated endothelia (Milici et al., 1985). We recently generated 
mutant mice that lack PLVAP and observed that endothelial diaphragms do not form in the 
absence of PLVAP (Herrnberger et al., 2012b). Depending on the respective genetic 
background, lack of diaphragms in Plvap-deficient mice interferes with cardiac 
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morphogenesis, the integrity of embryonic vessels and the formation of fenestrated 
endothelial layers. 
The endothelial lining of Schlemm's canal (SC) shows one of the highest hydraulic 
conductivities throughout the body allowing aqueous humor to pass from the anterior 
chamber via the trabecular meshwork into the lumen of SC. A specific requirement for the 
high hydraulic conductivity of SC appears to be the formation of large intracellular pores (I- 
and B-pores, respectively) with diameters of 0.1-2 µm (Johnson, 2006). In addition, solitary 
minipores with a diameter of about 60-65 nm and subtended by a diaphragm have been 
observed in the SC endothelium of monkey (Inomata et al., 1972) and human eyes (Tamm, 
2009b). SC minipores are essentially similar in size and structure to the diaphragmed 
fenestrae of fenestrated capillaries, but are much more rarely formed in SC endothelial cells 
than in those of fenestrated endothelia. It has been hypothesized that the large I-pores of SC 
originate from those minipores (Bill and Mäepea, 1995), a scenario which would be quite 
similar to that seen during embryonic development of pores in liver sinusoids and glomerular 
capillaries. Since the molecular processes that are required for SC pore formation are 
completely unclear, we hypothesized that PLVAP might be an important molecular target to 
shed more light on the processes governing aqueous humor flow across the endothelium of 
SC. We therefore investigated if PLVAP is localized and expressed in SC endothelial cells. 
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3.3 Materials and methods 
 
3.3.1 Tissues and animals  
 
Pig eyes (7-8 months, post mortem time 3-4 h) were obtained from local abattoir and human 
eyes (64-91 years, post mortem time 6-24 h) were obtained at autopsy. Methods for securing 
human tissue were humane, included proper consent and approval, and complied with the 
Declaration of Helsinki. For immunohistochemistry of normal mouse eyes, animals from CD1 
and NMR-1 genetic backgrounds were used. Mutant Plvap-deficient mice were established 
as described previously (Herrnberger et al., 2012b). Mutant Plvap-deficient mice in a 
C57BL/6N genetic background were crossed with TIE2GFP mice that are in a FVB-N genetic 
background. Eyes of wild-type, Plvap +/- and Plvap -/- littermates in a mixed C57BL/6N/FVB-N 
background (n= 6 for each genotype) were investigated. 
Genotyping was routinely performed by PCR analysis, using two upstream primers located in 
intron 1 of Plvap (5’-AGAGCCTTCTCTGCCAAGTG-3’) or in the inserted targeting cassette 
(5’-TCTCATGCTGGACTTCTTCG-3’), and a downstream primer located in intron 1 
downstream of the cassette (5’-GGCTAGCCTGAGCTACAGAGG-3’) resulting in a 672 bp 
PCR fragment for the wild-type allele and a 552 bp fragment for the targeted allele. 
 
 
3.3.2 Immunohistochemistry 
 
For immunohistochemistry, tissue samples were fixed in Carnoy's fixative (60 % methanol, 
30 % chloroform, and 10 % acetic acid) for 4 h and washed in 0.1 M phosphate buffer. The 
samples were equilibrated in 10, 20, and 30 % sucrose for 4 h and embedded in Tissue-Tek 
optimal cooling temperature (OCT) compound (Sakura Finetek Europe B.V., Zoeterwoude, 
NL) at -20 °C. After removal of Tissue-Tek, cryosections were blocked with 0.2 % cold water 
fish gelatin (Aurion, Wageningen, Netherlands), 1 % BSA and 0.1 % Triton-X (all in 0.1 M 
PBS) for 1 h at room temperature. After blocking, sections of pig and human eyes were 
incubated with mouse monoclonal antibodies (clone PAL-E, IgG2a, 1:50, Progen Biotechnik 
GmbH, Heidelberg, Germany) while sections from mouse eyes were treated with rat 
monoclonal antibodies pan ECA (clone MECA-32, IgG2a, 1:50, Santa Cruz) both specific 
against PLVAP (Ioannidou et al., 2006; Niemelä et al., 2005), and with the endothelial cell 
marker anti-CD31/PECAM-1 IgG (1:20, R&D Systems, Wiesbaden, Germany) for double 
labeling. Alexa Fluor 488 (1:1000) rabbit anti-mouse IgG (Invitrogen) and donkey anti-rat IgG 
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(1:2000) conjugated to Cy3 (Jackson Immuno Research) were used as secondary antibodies 
and incubated for 1 h at room temperature. 4′,6-Diamidino-2-phenylindole (DAPI) was used 
to counterstain nuclear DNA. Slides were mounted in a medium containing DAPI 
(Vectashield; Vector Laboratories, Burlington, CA, USA) and analyzed under a fluorescence 
microscope (Zeiss Axio Imager). For negative controls, primary antibodies were omitted and 
the slides were incubated with secondary antibodies only. 
 
 
3.3.3 Staining for β -galactosidase activity 
 
To study promoter activity, Plvap-deficient mice were used in which the Plvap locus had been 
modified by insertion of an IRES:lacZ trapping cassette and a floxed promoter-driven neo 
cassette inserted into intron 1 of Plvap (Herrnberger et al., 2012b). Eyes were fixed in 2.5 % 
glutaraldehyde in 5 mM EGTA (pH 7.3) and 2 mM MgCl2 dissolved in 0.1 M PBS for 4 h on 
ice with shaking. After three 30 min rinses in washing buffer (2 mM Mg Cl2, 0.01 % sodium 
deoxycholate, 0.02 % Nonidet-P40 in 0.1 M PBS), β -galactosidase activity was visualized in 
X-Gal staining solution (0.1 M PBS, 2 mM MgCl2, 0.01 % sodium deoxycholate, 0.02 % 
Nonidet-P40, 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, 1 mg/ml X-Gal). 
Eyes were stained for 24 h at 37 °C in the dark, washed 3 times for 5 min in washing buffer 
and embedded in paraffin. 
 
 
3.3.4 Transmission electron microscopy 
 
For transmission electron microscopy of mouse tissues, deeply anesthetized mice (120 
mg/kg of body weight i.m. ketamine and 8 mg/kg of body weight i.m. xylazine) were fixed by 
intracardial perfusions with 2.5 % glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4) each. 
Pig eyes were fixed by anterior chamber perfusion at 2 or 5 mmHg using the same fixative. 
After fixation, eyes were treated with 1 % OsO4, 0.8 % K4[Fe(CN)6] in 0.1 M cacodylate buffer 
for 1.5 h, dehydrated with graded ethanol solutions and embedded in Epon (Roth, Karlsruhe, 
Germany). Semithin sections were stained with Richardson’ stain (Richardson et al., 2009) 
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3.3.5 Quantitative analysis 
 
For quantitative analysis of the number of fenestrations in the choriocapillaris of Plvap -/- mice 
and wild-type littermates, the total number of fenestrations was counted along the side of 
capillaries facing the retinal pigmented epithelium (RPE) comprising a total length of 110 mm 
in wild-type animals and 306 mm in Plvap -/- mice. The number of fenestrations per mm 
capillary length was determined and expressed as mean ± SEM. Statistical analysis was 
done by a two-tailed Student's t-test and p values ≤ 0.05 were considered to be statistically 
significant. 
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3.4 Results 
 
Immunostaining with antibodies against PLVAP showed strong and specific labeling in the 
fenestrated endothelial cells of the choriocapillaris in mouse, pig (Figure 17) and human eyes 
(not shown). In contrast, capillaries of the retina with a continuous endothelial layer were only 
immunoreactive for antibodies against the endothelial cell marker CD31, but not for PLVAP 
(Figure 17). In the chamber angle of the pig eye, positive immunolabeling for PLVAP was 
observed in the endothelial cells of the aqueous plexus, which also stained for CD31 (Figure 
17). In contrast, no staining was observed in cells of the trabecular meshwork (Figure 17). 
Essentially comparable results were observed in sections through the human chamber angle 
where SC endothelial cells were labeled for both PLVAP and CD31, while TM cells were not 
immunoreactive for both types of antibodies (Figure 17). The capillaries of the ciliary muscle 
which have a continuous endothelial layer (Tamm and Lütjen-Drecoll, 1996) stained positive 
for CD31, but were not stained with antibodies against PLVAP (Figure 17). In the anterior 
mouse eye, staining for PLVAP was seen in the capillaries of the ciliary processes, which are 
of the fenestrated type (Tamm and Lütjen-Drecoll, 1996; Tamm, 2010). In addition, there was 
an intense staining of the endothelial cells of SC (Figure 17). In all three species, positive 
immunoreactivity for PLVAP was seen in the scleral collector channels of aqueous humor 
(Figure 17). 
 
 
Figure 17: Double immunolabeling with antibodies against both PLVAP (red) and CD31 (green).  Nuclear 
DNA was labeled with DAPI (blue). Immunostaining of retina and choroid with antibodies against PLVAP shows 
strong and specific labeling of the choriocapillaris in mouse and pig eye (solid white arrows). In contrast, 
capillaries of the retina are immunoreactive for antibodies against the endothelial cell marker CD31, but not for 
PLVAP (black arrows). In a frontal section through the chamber angle of a pig eye, positive immunolabeling for 
PLVAP is observed in the endothelial cells of the aqueous plexus (solid white arrows), which also stained for 
CD31. In a meridional section through the human chamber angle, SC endothelial cells are labeled for both 
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PLVAP and CD31 (solid white arrows). The capillaries of the ciliary muscle stain positive for CD31, but not for 
PLVAP (black arrows). In the anterior mouse eye, staining for PLVAP is seen in the capillaries of the ciliary body 
(black arrows) and the endothelial cells of SC (solid white arrows). Positive immunoreactivity for PLVAP is seen in 
the scleral collector channels (solid white arrowheads) and the choriocapillaris (black arrowhead). Re Retina, Ch 
Chroid, Sc Sclera, TM Trabecular meshwork, SS Scleral spur, CM Ciliary muscle, CB Ciliary body.  
 
 
We next investigated the eyes of Plvap-deficient mice. By light microscopy of semithin 
sections from 3-week-old Plvap -/- animals and their wild-type littermates, no obvious 
structural defects were observed in Schlemm's canal, trabecular meshwork and ciliary body 
(Figure 18).  
 
 
Figure 18: Semithin section (Richardson's stain) through the anterior eye of a 3-week-old Plvap 
-/-
 mouse 
and its wild-type littermate.  Schlemm's canal (asterisks), trabecular meshwork (arrows) and ciliary body (CB) 
are visible in both eyes. Sc. Sclera.  
 
 
Plvap promoter activity was assessed by staining for β-galactosidase in Plvap +/- and Plvap -/- 
mice with LacZ as a reporter gene inserted into the Plvap locus. Wild-type littermates did not 
stain for β-galactosidase, neither in retina and choroid of the posterior eye, nor in ciliary body, 
trabecular meshwork and Schlemm's canal endothelium of the anterior eye (Figure 19). In 
contrast, both Plvap +/- and Plvap -/- mice showed intense staining for β-galactosidase in the 
choriocapillaris essentially correlating with the results obtained by PLVAP 
immunohistochemistry. In the anterior eyes of Plvap +/- animals, a distinct labeling for β-
galactosidase was observed in endothelial cells of the ciliary body capillaries (Figure 19). 
Staining was also seen in some, but not all, cells of Schlemm's canal endothelium (Figure 
19). In contrast, in homozygous Plvap -/- mice, all endothelial cells of Schlemm's canal were 
labeled as were those of scleral collector channels (Figure 19). In the ciliary body of Plvap -/- 
animals, the entire stroma was strongly stained for β-galactosidase (Figure 19), a finding that 
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we attribute to diffusion of high amounts of reaction product from endothelial cells of ciliary 
body capillaries. Overall, the results obtained in mice with a knock-in of LacZ into the Plvap 
locus to visualize promoter activity strongly correlated with those obtained by PLVAP 
immunohistochemistry.  
 
 
Figure 19: Promoter activity of Plvap visualized by staining for the reporter gene β-galactosidase (blue).  
Panels on right hand side are higher magnifications of panels in the middle. Wild-type mice do not stain for β-
galactosidase, neither in retina and choroid of the posterior eye, nor in ciliary body, trabecular meshwork and 
Schlemm's canal endothelium (black solid arrows) of the anterior eye. Both Plvap 
+/-
 and Plvap 
-/-
 mice show 
intense staining for β-galactosidase in the choriocapillaris in sections through retina and choroid (solid black 
arrows), and in endothelial cells of ciliary body capillaries (white arrows) in sections through ciliary body, 
trabecular meshwork (TM) and Schlemm's canal (SC). In the ciliary body of the Plvap 
-/-
 animal, the entire stroma 
is strongly stained for β-galactosidase indicating stronger expression and diffusion of reaction product. In the 
Plvap 
+/-
 animal staining is also seen in some cells of Schlemm's canal endothelium (solid black arrows). In 
contrast, in the homozygous Plvap 
-/-
 mouse, all endothelial cells of Schlemm's canal are labeled (solid black 
arrows) as are those of scleral collector channels.  
 
 
Immunostaining for PLVAP was absent in eyes from Plvap -/- mice (Figure 20), but was seen 
in endothelial cells of Schlemm's canal, ciliary process capillaries and choriocapillaris in wild-
type littermates.  
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Figure 20: Immunostaining for PLVAP in the anterior eye of a 2-week-old wild-type mouse and its Plvap-
deficient littermate.  The wild-type animal shows positive immunoreactivity for PLVAP (red) in endothelial cells of 
Schlemm's canal (solid white arrow), ciliary body capillaries (black arrow) and choriocapillaris, whereas 
immunostaining for PLVAP is absent in the Plvap 
-/-
 littermate. Nuclear DNA was labeled with DAPI (blue). Re 
Retina, Sc Sclera.  
 
Since localization and expression of PLVAP were seen throughout the entire circumference 
of SC's endothelial wall while diaphragmed SC minipores have been reported to be only 
rarely present, we analyzed SC endothelium for the presence of caveolae with stomatal 
diaphragms. By transmission electron microscopy, the vast majority of SC caveolae in mouse 
(Figure 21), pig and human SC (not shown) showed a distinct diaphragm. Accordingly, the 
neck or stoma of the caveolae was bridged by a distinct, 5-7 nm thick, electron-dense 
diaphragm (Figure 21). Similar to those observed in human and monkey SC, we occasionally 
detected solitary minipores with a diaphragm in SC endothelial cells of mouse (Figure 21) 
and pig eyes (not shown). Minipores were considerably rarer than caveolae with stomatal 
diaphragms. In our material, we did not find conclusive evidence for the presence of 
transendothelial channels in SC endothelium. In contrast, caveolae with stomatal diaphragms 
were invariably absent in SC endothelial cells of Plvap -/- mice (Figure 21). Here, the neck of 
caveolae was not bridged by a diaphragm, but contained some ill-defined, fluffy electron-
dense material instead (Figure 21). Minipores with a diaphragm were not observed in SC 
endothelial cells of Plvap -/- mice. 
 
Chapter 3  57 
 
 
Figure 21: Transmission electron microscopy of SC endothelium in both wild-type and Plvap 
-/-
 mice. In 
the wild-type animal, caveolae with a stomatal diaphragm (black arrows) are seen in endothelial cells that form a 
giant vacuole (GV). In addition, solitary minipores with a diaphragm are observed (panel on right hand side, white 
arrow). In contrast, in the Plvap 
-/-
 mouse, the neck of caveolae is not bridged by a diaphragm, but contains some 
ill-defined, fluffy electron-dense material instead (black arrow). SC Schlemm's canal. Picture of fenestrae with 
fenestral diaphragm (upper right-handed picture) reproduced from Kathrin Ebner (Ebner, 2009), with permission.  
 
 
By transmission electron microscopy of the choriocapillaris in wild-type animals, numerous 
fenestrae with diaphragm were observed in areas in which the endothelial lining was thin and 
facing the basal side of the RPE (Figure 22). Fenestrae were commonly arranged in rows 
indicating their arrangement in typical sieve plates (Tse and Stan, 2010). In Plvap-deficient 
animals, endothelial cells of the choriocapillaris often appeared to be bi-layered on their RPE 
side, as they formed long and thin cytoplasmic protrusions that reached into the vascular 
lumen (Figure 22). Fenestrae were observed both on the endothelial side of the capillaries 
facing the RPE and in their luminal protrusions. None of the fenestrae was bridged by a 
diaphragm, but rather contained some fluffy and ill-defined electron-dense material (Figure 
22).  
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Figure 22: Transmission electron microscopy of choriocapillaris in 4-week-old wild-type and Plvap 
-/-
 
mice. In the wild-type animal, numerous fenestrae arranged in rows and covered by a diaphragm (black arrows) 
are seen in the endothelial cells adjacent to the retinal pigmented epithelium (RPE). In the Plvap 
-/-
 littermate 
endothelial cells form long and thin cytoplasmic protrusions that reach into the vascular lumen. Fenestrae are not 
bridged by a diaphragm, but are filled with fluffy, electron-dense material instead (black arrows). CC 
Choriocapillaris.  
 
 
In addition, the number of fenestrae was significantly reduced by about one third when 
compared to that of wild-types littermates (Figure 23). Essentially comparable structural 
changes were observed for the fenestrated capillaries of the ciliary processes (not shown). 
 
 
Figure 23: Quantitative analysis of the number of fenestrae per µm endothelial length in the 
choriocapillaris of wild-type and Plvap 
-/-
 mice.  N = 2 each, mean ± SD, ***p ≤ 0.001.  
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3.5 Discussion 
 
We conclude that PLVAP is expressed and localized in endothelia of aqueous humor outflow 
vessels, and is essential for the formation of endothelial diaphragms in the eye. The 
conclusions rest upon (1) the finding of specific immunoreactivity for PLVAP in endothelial 
cells of SC and aqueous plexus in mouse, pig and human eyes, (2) the expression of the 
reporter gene LacZ under the control of the Plvap promoter in SC endothelial cells of mutant 
Plvap +/- and Plvap -/- mouse eyes, (3) the observation of diaphragmed caveolae and 
minipores in SC endothelial cells, and (4) the absence of diaphragms in endothelia of SC, 
ciliary process capillaries and choriocapillaris in Plvap -/- mice. 
The deletion of PLVAP did not only cause the absence of diaphragms in vascular endothelial 
cells of the eye, but also led to a significant reduction in the number of fenestrae in 
fenestrated ocular capillaries. We recently reported quite comparable findings for the 
fenestrated capillaries in the pancreas or the peritubular interstitium of the kidney 
(Herrnberger et al., 2012b). While our findings indicate that PLVAP is essential for the 
formation of proper diaphragms in vascular endothelia, they also strongly indicate that 
PLVAP and/or diaphragms are important, although not essential, for the development of 
transendothelial pores. It is reasonable to assume that the fenestrae in the capillaries of the 
ciliary processes or the choriocapillaris play an important role in facilitating flow of water and 
solutes from the capillary lumen to the interstitium and vice versa. Plvap-deficient mice 
appear to be an ideal model to study if lack of fenestrae and absence of diaphragms cause 
changes in ciliary process and choroidal fluid dynamics, and if those changes impair the 
secretion of aqueous humor or retinal function. 
Since SC caveolae with diaphragm are considerably more numerous than SC diaphragmed 
minipores it is more than likely that they are the primary site of PLVAP immunolabeling. The 
specific function of caveolae with stomatal diaphragms is essentially unclear. It has been 
hypothesized that caveolae with stomatal diaphragms may fuse from luminal and abluminal 
sides of endothelial cells to form transendothelial channels which may then collapse to form 
diaphragmed fenestrae (Roberts and Palade, 2000). Diaphragmed fenestrae are very likely 
identical with the solitary diaphragmed minipores of SC (Inomata et al., 1972; Tamm, 2009a) 
which may burst in response to aqueous flow and open to the large size transient 
intracellular I-pores that are typical for this kind of endothelial layer. We did not observe any 
minipores in SC endothelial cells of Plvap-deficient mice, a finding which appears to indicate 
that their number has been substantially reduced, quite comparable to the number of 
endothelial fenestrae in the choriocapillaris. Still, SC minipores are also rare in wild-type 
animals, a fact that has precluded a quantitative analysis so far comparable to that we 
performed in the choriocapillaris. On the other hand, to test the functional role of PLVAP 
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and/or SC minipores in I-pore formation, it seems feasible to visualize I-pores by scanning 
electron microscopy and to quantify the number of I-pores, a study which is currently 
performed in our laboratory. Plvap-deficient mice appear to be an important model to study 
the biology of pore formation in SC endothelium. 
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Pore formation in the endothelial wall of liver 
sinusoids depends on plasmalemma vesicle-
associated protein (PLVAP) and is critically 
required for the passage of lipoproteins 
 
 
(adapted from: Leonie Herrnberger, Robert Hennig, Werner Kremer, Claus Hellerbrand, 
Achim Göpferich, Hans Robert Kalbitzer, and Ernst R Tamm.  
Pore formation in the endothelial wall of liver sinusoids depends on plasmalemma 
vesicle-associated protein (PLVAP) and is critically required for the passage of 
lipoproteins. Submitted) 
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4 Pore formation in the endothelial wall of liver sinusoids 
depends on plasmalemma vesicle-associated protein 
(PLVAP) and is critically required for the passage of 
lipoproteins 
 
4.1 Abstract 
 
Hepatic sinusoidal endothelial cells are characterized by the presence of fenestrations. The 
molecular mechanisms that control the formation of the fenestrations are unclear. Here we 
report that mice deficient in plasmalemma vesicle-associated protein (PLVAP) develop a 
distinct phenotype that is caused by the lack of sinusoidal fenestrations. PLVAP was 
expressed in endothelial cells of the liver in wild-type mice, but not in Plvap-deficient 
littermates. Plvap-/- mice suffered from a pronounced and highly significant reduction in the 
number of sinusoidal fenestrations which was seen by transmission and scanning electron 
microscopy. The lack of fenestrations was associated with an impaired passage of 
macromolecules such as FITC-dextran and quantum dot nanoparticles from the sinusoidal 
lumen into Disse’s space. Plvap-deficient mice showed a pronounced hyperlipoproteinemia 
as evidenced by milky plasma and the presence of lipid granules that occluded kidney and 
liver capillaries. By NMR spectroscopy of plasma, the nature of hyperlipoproteinemia was 
identified as massive accumulation of chylomicron remnants, while the amounts of low 
density and high density lipoproteins were reduced. At around three weeks of life, Plvap-
deficient livers developed extensive multivesicular steatosis, steatohepatitis, and fibrosis. 
PLVAP is critically required for the formation of fenestrations in sinusoidal endothelial cells. 
Lack of fenestrations caused by PLVAP deficiency substantially impairs the passage of 
chylomicron remnants between liver sinusoids and hepatocytes, and finally leads to liver 
damage. 
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4.2 Introduction 
 
Endothelial cells of liver sinusoids differ from that of other capillaries because of the presence 
of open fenestrations and the absence of a basal lamina (Aird, 2007b; Braet and Wisse, 
2002; McCuskey, 2008; Wisse et al., 1996). The diameter of the sinusoidal fenestrations 
varies between different species and measures 107 ± 1.5 nm (mean ± SEM) in the human 
liver (Wisse et al., 2008), while for the mouse liver diameters of 141 ± 5.4 nm (mean ± SEM) 
(Wisse et al., 2008), 99 ± 18 nm (mean ± SD) (Steffan et al., 1987) or 78 ± 12 (mean ± SEM) 
(Warren et al., 2010) have been reported. A specific function of liver sinusoids is the filtration 
of particles that are exchanged between the sinusoidal lumen and the space of Disse, 
allowing only particles smaller than the fenestrae to reach the hepatocytes or to leave the 
space of Disse (Wisse et al., 1985). Such a filter function appears to be especially important 
for the passage of lipoproteins. In support of this are observations of numerous chylomicron 
remnants with a size smaller than the diameter of fenestrations in the space of Disse of 
breastfeeded rat pups (Naito and Wisse, 1978). Moreover, multiple studies found evidence 
for a negative correlation between fenestration size and number, and the plasma 
concentration of larger lipoproteins (Braet and Wisse, 2002; Carpenter et al., 2005). 
 
The proliferation and survival of sinusoidal endothelial cells (Gerber et al., 1999), as well as 
their capability to form fenestrations (Carpenter et al., 2005), depend on vascular endothelial 
growth factor (VEGF) that is secreted from hepatocytes (Carpenter et al., 2005). Otherwise 
very little is known about the signaling mechanisms that modulate the maintenance and 
turnover of fenestrations in liver sinusoids. Multiple agents have been shown to modulate 
size and numbers of fenestrations (Braet and Wisse, 2002). Still, a common theme indicating 
a specific molecule that is part of the biological process which is required to form a pore in 
the wall of a sinusoidal endothelial cell in the liver has not been identified.  
 
Capillary endothelial cells of other organs with high demands for the passages of fluids and 
solutes differ from sinusoidal endothelial cells of the liver as they form fenestrae that are 
covered by a thin 5-6 nm non-membranous diaphragm (Aird, 2007a, 2007b). The only 
protein that has been identified to be a component of endothelial diaphragms is 
plasmalemma vesicle-associated protein (PLVAP, synonyms: MECA32, PV-1), an 
endothelial-specific, cationic, integral membrane glycoprotein (Stan et al., 1999a, 1999b). We 
and others recently showed that PLVAP is critically required for the formation of endothelial 
diaphragms which are completely absent in endothelia of Plvap-deficient mice (Herrnberger 
et al., 2012b; Stan et al., 2012). 
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Here we report that the absence of PLVAP in Plvap-deficient mice causes a pronounced 
reduction in the number of fenestrations in sinusoidal endothelial cells of the liver. Our results 
indicate that PLVAP is not only required for the formation of endothelial diaphragms, but also 
for the formation of endothelial fenestrae, even of those without diaphragms. The lack of 
sinusoidal fenestrations impairs the passage of macromolecules between the sinusoidal 
lumen and Disse’s space. A direct result is the presence of severe hyperlipoproteinemia 
caused by accumulation of chylomicron remnants in the plasma of Plvap-deficient animals. 
The phenotype provides clear molecular evidence for the assumption that open fenestrae in 
liver sinusoidal cells are critically required for the passage of lipoproteins. 
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4.3 Materials and Methods 
 
4.3.1 Animals 
 
All procedures conformed to the tenets of the National Institutes of Health Guidelines on the 
Care and Use of Animals in Research, the EU Directive 2010/63/E, institutional guidelines 
and the Uniform Requirements for Manuscripts Submitted to Biomedical Journals. Plvap-/- 
mice were used as described previously (Herrnberger et al., 2012b). Mice were kept in a 
mixed C57BL/6N/FVB-N background. All experiments were performed in mice of either sex. 
Genotyping was routinely performed by PCR analysis, using two upper primers located in 
intron 1 of Plvap (5’-AGAGCCTTCTCTGCCAAGTG-3’) and in the inserted cassette (5’-
TCTCATGCTGGACTTCTTCG-3’) and a lower primer located in intron 1 downstream of the 
cassette (5’-GGCTAGCCTGAGCTACAGAGG-3’) resulting in a 672 bp PCR fragment for the 
wild-type allele and a 552 bp fragment for the targeted allele. DNA was obtained from tail 
tips. PCR was performed in 15 µl reaction volumes containing standard buffer, 0.1 µM of 
each primer, 1 mM dNTPs, 2.5 mM MgCl2, 8% glycerol, 0.2 mM cresol red sodium salt 
(Sigma, Taufkirchen, Germany) and 0.25 U Taq-Polymerase (New England Biolabs, 
Taufkirchen, Germany). The cycling conditions consisted of an initial 3 min denaturing step at 
94°C, followed by 34 cycles for 30 s at 94°C, for 1 min at 65°C, and for 1 min 15 s at 72°C. 
 
 
4.3.2 Electron microscopy 
 
For transmission electron microscopy of mouse livers, deeply anesthetized mice (120 mg/kg 
body weight i.m. ketamine and 8 mg/kg body weight i.m. xylazine) were either fixed by 
intracardial perfusion with 2.5% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4) followed 
by immersion fixation in 2.5% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4) overnight, 
or by immersion fixation alone. Afterwards, livers were treated with 1% OsO4, 0.8% 
K4[Fe(CN)6] in 0.1 M cacodylate buffer for 1.5 h, dehydrated with graded ethanol solutions 
and embedded in Epon (Roth, Karlsruhe, Germany). Semithin sections were stained with 
Richardson’ stain (Richardson et al., 2009). Ultrathin sections were stained with uranyl 
acetate and lead citrate, and analyzed on a transmission electron microscope (Libra, Zeiss). 
For scanning electron microscopy of mouse livers, deeply anesthetized mice (120 mg/kg 
body weight i.m. ketamine and 8 mg/kg of body weight i.m. xylazine) were fixed by 
intracardial perfusion with 2.5% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4). Liver 
samples were isolated and further fixed by immersion in 2.5% glutaraldehyde in 0.1 M 
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cacodylate buffer (pH 7.4) overnight. After treatment with 1% OsO4, 0.8% K4[Fe(CN)6] in 0.1 
M cacodylate buffer for 1.5 h, the sample were rinsed in four changes of 0.1 M cacodylate 
buffer and immersed in 30% DMF dissolved in 0.1 M cacodylate buffer for 30 min. The liver 
samples were frozen with liquid nitrogen and were crushed into randomized pieces which 
were placed again in 30% DMF for 30 min, then rinsed twice with buffer and three changes of 
distilled water. The specimens were dehydrated in ascending acetone solutions and critical 
point dried using a CP drying apparatus E 3000 (Quorum Technologies Ltd, East Sussex, 
United Kingdom) with CO2 substitution (Anderson, 1951). Dried samples were sputter-coated 
with platinum and examined with a field-emission scanning electron microscope (LEO 1530, 
Zeiss). 
 
 
4.3.3 Perfusion studies 
 
For liver perfusion via the portal vein, mice were deeply anesthetized (120 mg/kg of body 
weight i.m. ketamine and 8 mg/kg body weight i.m. xylazine). The abdomen was opened and 
the portal vein was cannulated using a 27 gauge needle (Henry Schein, Melville, NY, USA). 
The needle was attached via disposable Mallinckrodt pressure tubing with an inner diameter 
of 0.050" and 24" length (Tyco Healthcare, Pleasanton, CA, USA) to a 3-way-stopcock 
(Fresenius Kabi AG, Bad Homburg, Germany). Two additional pressure tubes which are 
connected to two 10 ml syringes (Henry Schein, Melville, NY, USA) were attached to the 3-
way stopcock. For perfusion, an infusion pump (PHD 2000, Harvard Apparatus, Holliston, 
MA, USA) was used. Fluorescein isothiocyanate-dextran (FITC-dextran, FD70, Sigma, 
Taufkirchen, Germany) was dissolved at a concentration of 50 mg/ml in PBS. Qdot® 655 
ITK™ Amino (PEG) quantum dots (Life Technologies GmbH, Darmstadt, Germany) were 
perfused at a total amount of 20 pmol for each liver, with an infusion rate of 1 ml/min, and an 
infusion volume of 1 ml. After start of the perfusion, the inferior vena cava was cut open. To 
fix the tissue after perfusion, the 3-way-stopcock was switched to the syringe filled with 4% 
PFA and perfusion was restarted with an infusion rate of 1 ml/min and an infusion volume of 
1 ml. Finally, right liver lobes were collected and further processed for histology and 
immunohistochemistry.  
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4.3.4 Light microscopy 
 
Embryos were obtained from timed matings with noon of the day of vaginal plug discovery 
designated as 0.5 days of gestation (E0.5). Embryos and tissues were collected and fixed in 
4% PFA for 4 h. After fixation, embryos and tissue samples were washed in 0.1 M phosphate 
buffer, processed through several graded alcohol and xylenes, and embedded in paraffin. For 
frozen sections, the embryos and tissues were equilibrated in 10, 20, and 30% sucrose for 4 
h and embedded in Tissue Tek optimal cooling temperature (OCT) compound (Sakura 
Finetek Europe B.V., Zoeterwoude, NL) and cooled at -20°C. After removal of paraffin, the 
sections were stained with hematoxylin and eosin (H&E) and analyzed using a Zeiss Axio 
Imager microscope (Carl Zeiss AG, Oberkochen, Germany). For sirius red staining, de-
waxed sections were stained with Weigert's hematoxylin (1% Hematoxylin, pH 5.0-7.2 in 
96% isopropyl alcohol) for 8 min and then washed for 10 min in running tap water. Afterwards 
the sections were stained with 0.1% Picro-sirius in saturated aqueous solution (Waldeck 
GmbH & Co., Division Chroma, Münster, Germany) for 1 h. After two washing steps in 
acidified water (0.5% acetic acid diluted in distilled water), the water was physically removed 
from the slides and the sections were dehydrated through three steps of 100% ethanol for 10 
min. Afterwards the sections were cleared in two steps of 100% xylenes for 10 min, mounted 
with DePeX (Serva Feinbiochemica, Heidelberg, Germany) and examined using a Zeiss Axio 
Imager microscope (Carl Zeiss AG, Oberkochen, Germany). For staining for periodic acid 
schiff (PAS), de-waxed paraffin sections were oxidized by 1 % periodic acid dissolved in 70 
% ethanol for 10 min and washed 3 times in distilled water for 1min. Afterwards, the aldehyde 
groups are detected by Schiff reagent and counterstained with Weigert's hematoxylin (1% 
Hematoxylin, pH 5.0-7.2 in 96% isopropyl alcohol). Sections were processed through several 
graded alcohol and xylenes and mounted with DePeX (Serva Feinbiochemica, Heidelberg, 
Germany). For staining for β-galactosidase activity, embryos were fixed in 2% glutaraldehyde 
in 5 mM EGTA (pH 7.3) and 2 mM MgCl2 dissolved in 0.1 M PBS for 4 h on ice with shaking. 
After three 30 min rinses in washing buffer (2 mM MgCl2, 0.01% sodium deoxycholate, 
0.02% Nonidet-P40 in 0.1 M PBS), β-galactosidase activity was visualized in X-Gal staining 
solution (0.1 M PBS, 2 mM MgCl2, 0.01% sodium deoxycholate, 0.02% Nonidet-P40, 5 mM 
potassium ferrocyanide, 5 mM potassium ferricyanide, 1 mg/ml X-Gal). Tissues were stained 
for 24 h at 37°C in the dark, washed three times for 5 min in washing buffer, and embedded 
in Tissue-Tek for frozen sections. P-phenylendiamine (PPD, Carl Roth, Karlsruhe, Germany) 
staining was performed on semithin sections of liver and kidney. Sections were stained with 
1% PPD solution (10 mg/ml PPD in 98% ethanol) for 30 min at room temperature in the dark. 
Afterwards the sections were differentiated with 100% ethanol and counterstained with 
methylene blue. 
Chapter 4  68 
 
4.3.5 Immunohistochemistry 
 
Tissue samples were fixed in 4% PFA or Carnoy's fixative (60% methanol, 30% chloroform 
and 10% acetic acid) for 4 h, washed in 0.1 M phosphate buffer, and embedded in either 
paraffin or Tissue-Tek optimal cooling temperature compound (Sakura Finetek Europe B.V., 
Zoeterwoude, the Netherlands). For detection of PLVAP, CD31, and α-smooth muscle-actin, 
sections were blocked with 1% BSA, 0.2% cold water fish gelatin (Aurion, Wageningen, 
Netherlands), and 0.1% Triton-X (all in 0.1 M PBS) for 1 h at room temperature. After 
blocking, the sections were incubated with rat anti-panECA (MECA-32) IgG2a (1:50, Santa 
Cruz), goat anti-CD31/PECAM-1 IgG (1:20, R&D systems, Wiesbaden, Germany) or goat 
anti-α-smooth muscle-actin IgG (α-SMA) (1:200; GeneTex, Irvine, CA, USA). Donkey anti-rat 
IgG (1:2500) or rabbit anti-goat IgG (1:1000) conjugated to Alexa Fluor 488 (Life 
Technologies GmbH, Darmstadt, Germany) were used as secondary antibodies. For 
fibronectin staining, sections were blocked with 2% BSA and 0.1 M Triton-X in 0.1 M PBS for 
1 h. After blocking, sections were incubated with rabbit anti-fibronectin (1:500, Dako, 
Hamburg, Germany). Goat anti-rabbit IgG (1:1000) conjugated to Alexa 488 (Life 
Technologies GmbH, Darmstadt, Germany) were used as secondary antibodies. For IBA-1 
staining sections were pretreated with 0.05 M ammonium chloride for 30 min and with 0.5% 
Triton-X for 5 min. Afterwards, sections were blocked with 1% BSA, 0.2% cold water fish 
gelatin (Aurion, Wageningen, Netherlands), and 0.1% Triton-X (all in 0.1 M PBS) for 1 h at 
room temperature. After blocking, sections were incubated with rabbit anti IBA-1(1:100, 
Wako, Neuss, Germany). Goat anti-rabbit IgG (1:1000) conjugated to Alexa 488 (Life 
Technologies GmbH, Darmstadt, Germany) were used as secondary antibodies. Primary 
antibodies were always incubated overnight at 4°C and secondary antibodies were incubated 
for 1 h at room temperature in the dark. Slides were mounted with a medium containing 4',6-
Diamidino-2-phenylindole (DAPI, Vectashield; Vector Laboratories, Burlington, CA, USA) and 
analyzed under a fluorescence microscope (Zeiss, Axio Imager). For negative controls, 
primary antibodies were omitted and the sections were incubated with secondary antibodies 
only.  
 
 
4.3.6 TUNEL staining 
 
Apoptotic liver cells were detected by terminal deoxynucleotidyl transferase-mediated dUTP 
nick end labeling using the Deadend Fluorometric TUNEL system (Promega, Mannheim, 
Germany). Tissues were fixed in 4% PFA for 4 h. After removal of paraffin, TUNEL staining 
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was performed according to the manufacturer's instructions. Slides were analyzed under a 
fluorescence microscope (Zeiss, Axio Imager). 
 
 
4.3.7 Plasma analysis 
 
For collection of blood plasma for lipoprotein analysis, mice were euthanized with isoflurane 
and rapidly killed by decapitation to collect trunk blood. Blood samples were centrifuged at 
4000 g for 15 min and plasma was stored at - 20 °C. Hematocrit was evaluated by collecting 
trunk blood which was separated by standard laboratory methods using heparinized micro 
hematocrit tubes (Brand GmbH, Wertheim, Germany). Serum aspartate transaminase (AST), 
alanine transaminase (ALT), cholesterol, albumin and total protein levels were measured 
applying standard procedures. 
 
 
4.3.8 NMR spectroscopy 
 
NMR spectra were recorded on Avance 800 and 600 NMR spectrometers (Bruker Biospin 
Karlsruhe, Germany) operating at 800.2 and 600.2 MHz proton resonance frequencies, 
respectively. Both spectrometers were equipped with a cryoprobe for obtaining a higher 
sensitivity. Spectra were recorded from blood plasma of individual mice at 310 K. If the 
sample volume was smaller than 500 L, an appropriate amount of physiological 
extracellular buffer (Freund and Kalbitzer, 1995) was added up to 500 L. Quantification of 
the plasma lipoproteins was obtained from NOESY-type 1D spectra (Beckonert et al., 2007) 
and a set of Oneshot (Pelta et al., 2002) diffusion weighted 1H NMR spectra. The 
concentrations of the different lipoprotein subclasses defined by the hydrodynamic radii rH 
was calculated according to methods published previously (Huber et al., 2005; Pelta et al., 
2002). Chemical shifts  and hydrodynamic radii rH were referenced to the methyl signal of 
lactate used as internal standard. The chemical shift of lactate was set to 1.365 ppm, since it 
is known that the usual reference compound DSS interacts with the lipoproteins. The 
hydrodynamic radius of Tris-buffer was experimentally determined as 0.307 nm in a separate 
set of experiments and used for the calibration of the hydrodynamic radii of the triplet signal 
in the lipoproteins. The obtained rH-values were associated with different types of lipoproteins 
from the data published for human lipoprotein subclasses (Petersen et al., 2012). The 
relative concentration changes of the different lipoproteins were calculated for 3 samples 
each of wild-type and Plvap-/- littermates. 
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4.3.9 Quantitative analysis 
 
For quantitative analysis of the number of fenestrations in liver sinusoids, the total number of 
fenestrations was counted along the endothelium comprising a total length of 2.5 mm in both 
wild-type and Plvap-/- littermates. The number of fenestrations per µm capillary length was 
determined and expressed as mean ± SEM. Statistical analysis was done by a two-tailed 
Student's t-test and p values ≤ 0.05 were considered to be statistically significant. 
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4.4 Results 
 
4.4.1 The loss of PLVAP in sinusoidal endothelial cells is associated with a lack of 
fenestrations 
 
To analyze the expression of Plvap in the developing liver, we stained for β-galactosidase to 
detect the expression of the reporter gene lacZ. At embryonic day (E) 15.5, a time when 
fenestrations have been formed in the sinusoids of the mouse liver, we detected a positive 
staining in the sinusoidal endothelial cells of Plvap-deficient embryos (Figure 24A). In 
contrast, staining was essentially absent in wild-type littermates (Figure 24A). The β-
galactosidase staining in the liver sinusoidal endothelium was patchy and considerably 
weaker than the more homogenous staining in the capillaries of the immediately adjacent 
small intestine or skin (Figure 24A) which show strong Plvap expression (Herrnberger et al., 
2012b). Comparable results were obtained when localization of PLVAP was investigated by 
immunohistochemistry. At E16.5, liver sinusoidal cells of wild-type embryos showed a distinct 
immunoreactivity for PLVAP, a finding that was not observed in Plvap-/- embryos (Figure 24B). 
The immunoreactivity was patchy and weaker than in the capillaries of the adjacent small 
intestine or pancreas (Figure 24B). In three-week-old mice the immunoreactivity for PLVAP in 
the sinusoidal endothelial cells of wild-type animals was of similar intensity than in embryos, 
but more homogenous (Figure 24C). Again, no immunoreactivity for PLVAP was observed in 
Plvap-/- littermates (Figure 24C).  
 
PLVAP is a component of the diaphragms covering endothelial fenestrae, transendothelial 
channels, and caveolae (Stan, 2005; Stan et al., 1999a). Since the formation of fenestrae 
with diaphragms precedes that of open fenestrae during development of the sinusoidal 
endothelium in rat embryos (Bankston and Pino, 1980), we assumed that the PLVAP staining 
in the mouse embryos was associated with the formation of diaphragmed fenestrae. Indeed, 
we observed fenestrae with a diaphragm in the sinusoidal endothelium of mouse embryos 
starting from E12.5 (Figure 24D). As expected, fenestrae of sinusoidal endothelial cells in 
three-week-old mice were open while fenestrae or transendothelial channels covered by 
diaphragms were not observed (Figure 25A). Also caveolae which were only rarely observed 
in sinusoidal endothelial cells of wild-type pups after birth did not form stomatal diaphragms 
(Figure 24E), a finding that was corroborating results from a previous report (Ghitescu and 
Fixman, 1984). Overall, our data did not support the concept that the presence of PLVAP in 
sinusoidal endothelial cells of the postnatal mouse liver is associated with the presence of 
endothelial diaphragms.  
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Figure 24: PLVAP in the liver. A, β-galactosidase stained sections through the liver of a Plvap
-/-
 animal and its 
wild-type littermate at E15.5. Staining is seen in the sinusoidal endothelium of the Plvap-deficient embryo (white 
arrows), but not in the wild-type. Staining in the liver is patchy and weaker than the homogenous staining of 
capillaries in the small intestine (In, black arrows) or skin (Sk, arrowheads). Lower panels show magnification of 
the staining in liver sinusoids (white arrows). B, Immunolabeling for PLVAP (red) shows staining in the sinusoidal 
endothelium of a wild-type embryo at E16.5 (boxed areas in the left panel). Stronger immunostaining for PLVAP is 
seen in capillaries of the small intestine (white arrow) and the pancreas (black arrow). No staining is seen in the 
Plvap-deficient littermate (right panel). Middle panel shows magnification of the boxed panel. C, Liver staining for 
PLVAP (red) at P11 shows positive immunoreactivity in wild-type sinusoidal endothelium, but not in the Plvap
-/-
 
littermate. Nuclear DNA is labeled with DAPI (blue). D and E, TEM. Fenestrations bridged by 5- 7 nm thick 
diaphragms (black arrows) are seen in wild-type sinusoidal endothelium at E12.5 (D). Caveolae of wild-type 
sinusoidal endothelium at P20 are not bridged by stomatal diaphragms (black arrow, E).  
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We next analyzed whether sinusoidal endothelial cells of Plvap-deficient mice show 
ultrastructural changes when compared to wild-type littermates. By TEM, numerous 
fenestrae were observed in sinusoidal endothelial cells of wild-type animals at three weeks of 
age (Figure 25A). In contrast, fenestrae were only very rarely observed in the sinusoidal 
endothelium of Plvap-deficient littermates (Figure 25A). Moreover, in Plvap-/- mice the space 
of Disse was compressed and filled with fine granular electron-dense material which was 
observed adjacent to the hepatocyte microvilli and was not present in wild-type littermates 
(Figure 25A). The lack of fenestrae in sinusoidal endothelial cells of Plvap-deficient mice was 
confirmed by SEM. Sinusoidal endothelial cells in wild-type mice displayed numerous 
fenestrae that were arranged in sieve plates (Figure 25B). In contrast, sinusoidal endothelial 
cells of Plvap-deficient mice showed only very few fenestrations which formed individual 
openings instead of being arranged in clusters (Figure 25B). The diminished porosity of the 
sinusoidal endothelium was verified by quantification which showed a highly significant (p ≤ 
0.001) and approximately 6.2-fold reduction in the number of fenestrae in Plvap-deficient 
mice (Figure 25C). 
 
 
Figure 25: Ultrastructure of Plvap-deficient sinusoids. A,  TEM of a 3-week-old wild-type animal shows 
numerous fenestrations in sinusoidal endothelial cells (black arrows). In contrast, fenestrations are very rare in the 
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Plvap
-/-
 littermate (black arrow). Lower panels show magnification. While in the wild-type animal Disse’s space 
(Di) is open, it is compressed and filled with fine granular electron-dense material in the Plvap-deficient littermate 
(white arrows). He, hepatocyte, Lu, sinusoidal lumen. B, SEM of a 3-week-old wild-type animal shows the 
arrangement of fenestrations (arrows) in sieve plates. In contrast, sinusoidal endothelial cells of a Plvap-deficient 
littermate show only few fenestrations (arrows) which form individual openings. C, Quantitative analysis of 
fenestrations per µm endothelial length in sinusoids of wild-type and Plvap
-/-
 animals. N = 5, mean ± SEM, 
***
p = 
0.00069.  
 
 
4.4.2 The lack of fenestrations leads to a decrease in the permeability of sinusoidal 
endothelial cells 
 
We next analyzed if the absence of PLVAP and the decrease in the number of fenestrations 
in sinusoidal endothelial cells was associated with major changes in sinusoid architecture. To 
this end we labeled the vascular endothelial cells of the liver with antibodies against CD31 
and detected no obvious differences between Plvap-/- mice and wild-type littermates with 
regards to orientation and density of positively-labeled vascular endothelial cells (Figure 
26A). No obvious structural differences in the architecture of liver sinusoids were observed 
when semithin sections were studied (Figure 26B). A distinct difference though between the 
sinusoids of Plvap-deficient mice and that of wild-type littermates was the higher number of 
mononuclear cells (presumably Kupffer cells) in the lumen of the Plvap-/- sinusoids (Figure 
26B). In addition, livers of Plvap-/- mice showed areas with accumulations of mononuclear 
cells in Disse’s space (Figure 26B). We next tested the permeability of the sinusoids for 
macromolecules by perfusion with 70 KDa FITC-dextran possessing a hydrodynamic 
diameter of approx. 10 nm via the portal vein. After perfusion of wild-type animals, a strong 
FITC-signal was detected throughout the entire liver. Immunolabeling with CD31 strongly 
suggested that numerous FITC-dextran molecules had passed the endothelial cells via their 
fenestrae and had accumulated in the space of Disse (Figure 26C). In contrast, in Plvap-
deficient littermates a signal for FITC-dextran was barely detectable (Figure 26C). In a 
parallel approach, we used 25 nm diameter quantum dots18 holding a CdSe-containing core 
for portal vein perfusion (quantum dots were provided by Prof. Dr. Achim Göpferich and 
confocal microscopy (data not shown) was done with the help of Robert Hennig). The core 
allowed us to measure the amount of cadmium per kg liver tissue by inductively coupled 
plasma mass spectrometry (ICP-MS), which correlates with the amount of quantum dots in 
the tissue after perfusion. Only 0.05 mg/kg cadmium were detected in the liver homogenate 
from a Plvap-deficient mouse while the liver of the wild-type littermate contained 1.2 mg/kg 
cadmium (ICP-MS was conducted by Firma Friedle, Regensburg, Germany). Overall, our 
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experiments strongly supported the assumption of a constrained passage of macromolecules 
and nanoparticles through the hepatic sinusoidal endothelium of Plvap-deficient mice. 
 
 
Figure 26: Diminished permeability of liver sinusoids in Plvap-deficient mice. Neither by 
immunohistochemistry with antibodies against CD31 (A) nor light microscopy of 1 µm semithin sections (B, 
Richardson’s stain) obvious differences are detected with regards to the overall orientation and the density of liver 
sinusoids between 3-week-old Plvap
-/-
 mice and wild-type littermates. Sinusoids of Plvap-deficient mice show a 
higher number of macrophages in their lumen (white arrows) and focal areas with accumulations of mononuclear 
cells in Disse’s space (black arrows). Lower panels in B show higher magnifications. C, After perfusion of a wild-
type animal with FITC-dextran, a strong FITC-signal (green) throughout the liver is detected. Immunolabeling with 
CD31 (red) suggests that FITC-dextran molecules have accumulated in the space of Disse. In contrast, in the 
Plvap-deficient littermate, the signal for FITC-dextran is much weaker and barely detectable. Nuclear DNA is 
labeled with DAPI (blue).  
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4.4.3 The lack of sinusoidal fenestrae in Plvap-deficient mice causes 
hyperlipoproteinemia and steatosis 
 
We next hypothesized that the loss of sinusoidal fenestrations in Plvap-/- mice should impair 
the passage of chylomicron remnants to hepatocytes, and analyzed the animals for signs of 
hyperlipoproteinemia. Plasma isolated from 10-day-old breastfeeding Plvap-deficient pups 
was whitish, milky and thus strongly indicative of hyperlipoproteinemia (Figure 27A). In 
contrast, plasma from wild-type littermates appeared clear. Upon macroscopic analysis of 2- 
to 3-week-old Plvap-/- animals, the blood in the vessels supplying the small intestine or the 
kidneys had a milky color, while that of wild-type animals was red (Figure 27B). In contrast to 
the kidneys of wild-type animals, which had an intense reddish color, those of Plvap-deficient 
littermates were pale (Figure 27B). A similar difference in color was observed upon 
macroscopic analysis of the livers (Figure 27B). The differences in color were not caused by 
anemia, as no obvious differences in hematocrit readings were observed between Plvap-/- 
animals and their wild-type littermates (Figure 27A).  
 
 
Figure 27: Hyperlipoproteinemia in Plvap-deficient mice. A, Plasma of a P10 Plvap-deficient pup looks milky 
(arrows), while that from a wild-type littermate is clear. No obvious differences in hematocrit readings are 
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observed between a Plvap
-/-
 pup and its wild-type littermate (right-handed panel). B, The blood in the mesenterial 
or kidney vessels of a 3-week-old Plvap-deficient animal is milky (white arrows), while that of wild-type animals is 
red. Boxed area displays a magnification of mesenteric capillaries that are cut open to show milky blood (black 
arrow). Kidneys and livers of wild-type animals are of reddish color (black arrows), while those of Plvap-deficient 
littermates are pale.  
 
 
To clarify, if the differences in kidney or liver colors were caused by hyperlipoproteinemia, we 
analyzed semithin sections of mice at three weeks of age, which is close to the maximal life 
span of our Plvap-deficient animals. When kidney sections of Plvap-/- mice were labeled with 
the lipid stain PPD, abundant granular structures were identified that filled the peritubular and 
glomerular capillaries (Figure 28A). In contrast, in kidneys of wild-type littermates only 
erythrocytes were seen in the capillary lumen (Figure 28A). By TEM, the granular structures 
in the lumen of Plvap-deficient capillaries were identified as homogenously electron-dense 
particles with diameters between 50 to 500 nm (Figure 28B). The particles were surrounded 
by extracellular fibrils with the ultrastructural characteristics of fibrin indicating thrombus 
formation. When semithin sections through the livers of Plvap-deficient animals were stained, 
PPD-labeled granular structures were identified in the lumen of liver sinusoids and in Kupffer 
cells (Figure 28B). The cytoplasm of the vast majority of hepatocytes was densely filled with 
PPD-labeled granules (Figure 28B). Similar granules were only occasionally observed in 
hepatocytes of wild-type littermates (Figure 28B). By TEM, the cytoplasmic granules were 
identified as liposomes indicating a pronounced microvesicular steatosis in Plvap-deficient 
livers (Figure 28B). Hepatocytes of wild-type animals contained large aggregates of 
glycogen, which were absent in Plvap-deficient littermates (Figure 28B). Similar to the 
findings in kidney capillaries, the lumen of liver sinusoids in Plvap-/- animals was frequently 
occluded by aggregates of fibrillar fibrin suggestive of thrombus formation (Figure 28B). 
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Figure 28: Lipoproteins in capillaries and hepatocytes of Plvap-deficient animals. A, PPD-labeled granular 
structures fill the lumen of kidney capillaries in a 3-week-old Plvap
-/-
 mouse (arrows, boxed area, counterstain: 
Richardson’s stain), while only erythrocytes are seen in the wild-type littermate (arrow, boxed area). B, The 
granular structures (black arrows) in the lumen of Plvap-deficient capillaries have diameters between 50 to 500 
nm and are homogenously electron-dense. The particles are surrounded by extracellular fibrils with the 
ultrastructural characteristics of fibrin (white arrow) (TEM, lower panel shows higher magnification). C, PPD-
labeled granular structures are seen in the lumen of liver sinusoids in a Plvap
-/-
 mouse but not in a wild-type 
littermate (white arrows). The cytoplasm of the vast majority of Plvap
-/-
 hepatocytes is densely filled with PPD-
labeled granules (black arrows) which are rare in hepatocytes of wild-type littermates (black arrows). D, By TEM, 
numerous liposomes (black arrows) are seen in the Plvap-deficient liver indicating a pronounced microvascular 
steatosis. Hepatocytes of the wild-type animal contain large aggregates of glycogen (asterisks), which are absent 
in hepatocytes of the Plvap-deficient littermates. The lumen of Plvap
-/-
 liver sinusoids is occluded by fibrillar fibrin 
(white arrows) suggestive of thrombus formation (Figure 28D).  
 
 
4.4.4 Increase in plasma chylomicron remnants in Plvap-deficient mice 
 
To obtain molecular information on the nature of the particles that caused 
hyperlipoproteinemia in Plvap-deficient mice, we performed pulsed gradient stimulated echo 
NMR experiments and analyzed lipoprotein size and concentration changes between wild-
type and Plvap-deficient mice (Figure 29). The data were evaluated analogously to a well-
established method for analysis of human lipoproteins by NMR spectroscopy (Huber et al., 
2005; Petersen et al., 2012). For the analysis of the nature of the respective lipoproteins, the 
nomenclature used for human lipoproteins which are defined by their hydrodynamic radii was 
used (Huber et al., 2005; Petersen et al., 2012). Peaks labeled with CH3 containing the 
signals of the methyl groups of fatty acids of complex lipids and some cholesterol signals 
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were analyzed. Evidently, the shape and intensity of the peaks were different between wild-
type and Plvap-/- mice (Figure 29A). A triplet signal for lipoproteins with a hydrodynamic 
radius of 80-100 nm (subclass 13) and largely corresponding to the sizes of chylomicron 
remnants was increased dramatically in Plvap-deficient mice (Figure 29A, B). A much smaller 
increase was observed for lipoproteins with sizes between 40 and 80 nm (subclasses 12, 
11). Within the limits of error, lipoproteins with sizes between 25 and 40 nm were unchanged, 
but all smaller lipoproteins (subclasses 8-1) corresponding to low-density lipoproteins (LDL) 
and high-density lipoproteins (HDL) were almost completely abolished in Plvap-/- mice. The 
relative concentration of large chylomicrons with diameters > 150 nm (subclass 15) was 
somewhat decreased in the plasma of Plvap-deficient mice. 
 
 
Figure 29: NMR spectroscopy of wild-type and Plvap-deficient plasma. A, Part of 600 MHz 1H NMR spectra 
of wild-type and Plvap
-/-
 mice at different gradient strengths displaying the (CH3) signals from the methyl groups 
of the lipids of lipoproteins with maximum gradient strength of 0.535 T/m ± 0.01 T/m determined with a water 
reference sample, the different colors represent different gradient strengths. A strong decrease of the signal 
intensity corresponds to a small hydrodynamic radius. B, Average difference (black bars) of the relative particle 
numbers ΔNrel in the lipoprotein subclasses L15 to L1 (Huber et al., 2005; Petersen et al., 2012) between wild-
type and Plvap
-/-
 mice. The red bar indicates the signal intensity difference of the triplet signal visible in the Plvap
-/-
 
mice shown in A. Experiments performed by Prof. Dr. Werner Kremer and Prof. Dr. Dr. Hans Robert Kalbitzer, 
Institut für Biophysik und Physikalische Biochemie, Lehrstuhl für Biophysik, Universität Regensburg. 
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4.4.5 Steatosis in Plvap-deficient mice progresses to necrosis and fibrosis 
 
Since hepatic steatosis potentially progresses to severe liver disease, we analyzed the livers 
of three-week-old Plvap-deficient mice and observed that the surface of wild-type livers was 
smooth while that of Plvap-/- mice showed scar tissue (Figure 30A). By light microscopy of 
Plvap-/- livers at postnatal day (P) 18, we consistently observed focal necrotic areas (Figure 
30B) containing numerous TUNEL-positive nuclei (Figure 30C). Immunostaining for IBA-1 at 
P18 identified a pronounced increase in the number of macrophages in Plvap-/- livers when 
compared to wild-type littermates (Figure 30D). By staining with sirius red numerous 
intensely stained focal areas were detected indicating a pronounced focal increase in the 
amounts of extracellular matrix (Figure 30E). In contrast, in wild-type littermates positive 
staining for sirius red was only seen around larger hepatic vessels (Figure 30E). Intense 
staining for PAS was seen in the cytoplasm of wild-type hepatocytes (Figure 30F) and 
correlated with the presence of glycogen aggregates that were identified by TEM (Figure 
28D). Hepatocytes were not reactive for PAS in livers of Plvap-/- littermates (Figure 30F). In 
contrast, numerous focal areas of positive extracellular PAS-labeling were observed (Figure 
30F). By immunohistochemistry of P18 Plvap-/- livers, we regularly observed foci with 
accumulations of α-smooth muscle actin-positive cells (α-SMA) (Figure 30G). In the liver, α-
SMA is a specific marker for activated hepatic stellate cells (HSC), which are the cellular 
source of increased extracellular matrix (ECM) formation and deposition in response to 
hepatic injury (Hellerbrand, 2013). Similar areas showed an increase in immunoreactivity for 
fibronectin (Figure 30H). Focal areas that stained for fibronectin or α-smooth muscle positive 
cells were essentially absent in the livers of wild-type littermates (Figure 30G, H). Together, 
these data indicate HSC activation and enhanced fibrogenesis in P18 Plvap-/- livers.  
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Figure 30: Liver fibrosis and necrosis in Plvap-deficient mice. A, The surface of a wild-type liver at three 
weeks of age is smooth while that of a Plvap
-/-
 mouse shows scars (white arrows). B, H&E stained paraffin section 
through the liver of a P18 Plvap
-/-
 animal shows a focal necrotic area (white arrows). Similar areas are not seen in 
the wild-type littermate. C, Numerous TUNEL-positive nuclei (white arrows) accumulate in a focal necrotic area of 
the P18 Plvap
-/-
 animal shown in B. In contrast, only individual TUNEL-positive cells are rarely seen in the wild-
type littermate (black arrows). D, Immunostaining for IBA-1 (green) at P18 shows a higher number of 
macrophages (white arrows) in the Plvap
-/-
 liver when compared to the wild-type littermate. E, A sirius red stained 
focal area in the liver of an P17 Plvap
-/-
 mouse indicates focal fibrosis (white arrows). In the wild-type littermate 
positive staining for sirius red is only seen around larger hepatic vessels. F, Intense staining for PAS is seen in 
the cytoplasm of wild-type hepatocytes. In contrast, hepatocytes are not reactive for PAS in the liver of a Plvap
-/-
 
littermate with focal areas of positive extracellular PAS-labeling (black arrows). G, α-SMA-positive cells 
accumulate in the liver parenchyma of a Plvap
-/-
 mouse (white arrows), but are only seen in the walls of blood 
vessels in the wild-type littermate. H, A similar area as in G shows immunoreactivity for fibronectin in the liver of a 
Plvap
-/-
 mouse (white arrows). Staining for fibronectin is essentially absent in the liver of the wild-type littermate. 
Nuclear DNA is labeled with DAPI (blue).  
 
 
To assess functional parameters of the liver, we performed chemical plasma analysis and 
observed a decrease in the amounts of total protein and albumin in the plasma of Plvap-/- 
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mice (Figure 31). Cholesterol was highly increased consistent with the accumulation of 
relative cholesterol-rich chylomicron remnants. In some, but not all Plvap-/- animals, the 
amounts of AST and ALT were increased.  
 
 
Figure 31: Plasma analysis of wild-type and Plvap
-/-
 mice. mean ± SD. Analysis was performed by the 
Klinische Chemie, Universitätsklinikum Regensburg. 
 
Finally, we investigated Disse’s space by TEM. Here we regularly observed bundles of 
collagen fibrils with the typical 67 nm periodicity of collagen types I or III in Plvap-deficient 
animals at three weeks of age (Figure 32). In contrast, no fibrillar extracellular matrix was 
seen in Disse’s space of wild-type littermates (Figure 32). 
 
 
Figure 32: Accumulation of collagen in livers of Plvap-deficient mice. By TEM of a Plvap-deficient animal at 
three weeks of age, bundles of collagen fibrils with the typical 67 nm periodicity are seen in Disse’s space 
(arrows). No fibrillar extracellular matrix is present in Disse’s space of the wild-type littermate. Lower panels show 
higher magnification.   
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4.5 Discussion 
 
We conclude that PLVAP is required for the formation of fenestrations in liver sinusoidal 
endothelial cells. The reduced permeability impairs the passage of chylomicron remnants 
and other lipoproteins between the lumen of liver sinusoids and hepatocytes, a scenario that 
causes hyperlipoproteinemia and results in liver injury. The conclusions rest upon (1) the 
finding of a substantial reduction in the number of fenestrations (2) the observation of an 
impaired passage of macromolecules and nanoparticles between sinusoids and Disse’s 
space (3) the presence of a massive accumulation of plasma chylomicron remnants (4) the 
reduction in plasma LDL and HDL, and finally (5) the development of multivesicular steatosis, 
steatohepatitis, focal liver necrosis, and fibrosis in Plvap-deficient animals. 
 
The important role of PLVAP in transcellular pore formation appears not to be restricted to 
the formation of fenestrations in the liver. When transcellular pores are generated by vascular 
endothelial cells to allow leukocyte migration, PLVAP forms a ring that surrounds the 
migrating lymphocytes and which is supported by vimentin filaments which physically interact 
with PLVAP (Keuschnigg et al., 2009). Moreover, blocking of PLVAP by antibodies resulted in 
a decrease in the number of migrating leukocytes (Keuschnigg et al., 2009). Studies on the 
mechanism of fenestration formation in liver sinusoids identified cytoskeletal rings around the 
fenestrations (Braet et al., 1998, 1996). The formation of fenestrations was significantly 
induced following experimental disruption of the cortical actin fibers (Braet et al., 1998, 1996; 
Svistounov et al., 2012) and originated from a distinct focal area that was termed “fenestrae-
forming center” (Braet et al., 1998). The entire process occurred rapidly and likely required 
no de novo protein synthesis (Braet et al., 1998, 1996). 
It is tempting to speculate that PLVAP molecules in or close to the plasma membrane are 
required to facilitate local actin disruption and pore formation, processes that are significantly 
less likely to occur in the absence of PLVAP. PLVAP is essential for the formation of 
endothelial diaphragms (Herrnberger et al., 2012b; Stan et al., 2012) and in recent studies 
we observed a reduction in the number of diaphragmed fenestrations in the Plvap-/- pancreas 
(Herrnberger et al., 2012b) or the choroid (Herrnberger et al., 2012a). In the liver, we found 
endothelial diaphragms in wild-type fetal sinusoids, but not after birth and regard it as unlikely 
that the formation of an endothelial diaphragm by PLVAP is a prerequisite for the formation of 
fenestrations in liver sinusoids. Data from in vitro studies are consistent with this assumption 
Braet et al., 1998, 1996). 
 
The accumulation of chylomicron remnants in the plasma of Plvap-/- mice supports the 
concept that the structural characteristics of liver sinusoidal endothelial cells, like the 
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presence of open fenestrations and the absence of a basal lamina, have developed in 
evolution to allow passage of lipoproteins that are small enough in size (Braet and Wisse, 
2002; Fraser et al., 1995a). Dietary lipids are absorbed by enterocytes and packaged into 
triglyceride-rich chylomicrons (Mansbach and Siddiqi, 2010). Chylomicrons have diameters 
between 75 nm and 1200 nm (Jonas and Phillips, 2008; Petersen et al., 2012) and cannot 
pass the endothelial wall of the diaphragmed fenestrated capillaries in the intestine which 
allow passage of particles with sizes between 6 and 12 nm (Sarin, 2010). Instead, 
chylomicrons enter the lymphatic capillaries which have a discontinuous endothelial layer 
(Lee et al., 2010). Chylomicrons reach the blood via the thoracic duct where most of their 
triglycerides are rapidly removed by lipoprotein lipase (LPL), an enzyme localized at the 
surface of capillaries in adipose and muscular tissues. Cholesterol-rich chylomicron 
remnants are finally taken up in the liver, a process that requires passage across the 
sinusoids and binding to both LDL receptor (LDLR) and LDL receptor-related protein (LRP) 
on hepatocytes (Willnow, 1997; Willnow et al., 1995). Mice that are deficient in LDLR and 
LRP show a comparable plasma increase in the amounts of chylomicron remnants and total 
cholesterol as Plvap-/- mice (Willnow et al., 1995). 
 
It is tempting to speculate that the reduced number of fenestrations in Plvap-/- mice hinders 
not only the passage of chylomicron remnants, but also that of hepatocyte-derived 
lipoproteins towards the sinusoidal lumen. Our methods do not allow specifically assessing 
the amounts of plasma very low density lipoproteins (VLDL), since the hydrodynamic radii of 
chylomicron remnants and VLDL overlap, and chylomicron remnants trapped in the plasma 
are further reduced in their diameters by the activity of LPL.  
Still, the markedly reduced amounts of LDL and HDL indicate that lack of fenestrations in 
sinusoidal endothelia does not only interfere with the passage of lipoproteins from the 
sinusoidal lumen to Disse’s space, but also vice versa. VLDL are assembled in hepatocytes 
and converted to LDL in the plasma, while HDL are formed at the surface of hepatocytes 
(Cohen and Fisher, 2013; Fisher et al., 2012). Liver-derived lipoproteins which are not 
capable of passing the endothelial layer of Plvap-/- sinusoids would not accumulate in Disse’s 
space, but be drained by the liver lymphatics to the abdominal lymph nodes (Chung and 
Iwakiri, 2013). A reduced protein synthesis in Plvap-/- hepatocytes compromised by steatosis 
and steatohepatitis provides an alternative explanation for the reduced plasma amounts of 
LDL and HDL. In support of this possibility are the reduced plasma amounts of total protein 
and albumin in Plvap-/- animals.  
Finally, the loss of endothelial diaphragms in capillaries outside the liver might be a 
contributing factor to hypoproteinemia and low plasma levels of small size lipoproteins such 
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as LDL and HDL which might increasingly pass through fenestrations that are normally 
bridged by a diaphragm, but are more permeable in Plvap-/- mice. 
Stan and colleagues reported recently on the phenotype of Plvap-deficient mice that were 
bred in a genetic background (hybrid intercrosses containing a mix of Balb/c, C57Bl/6J and 
129Sv/J) different from our animals (Stan et al., 2012). The authors observed similar plasma 
changes as reported here. Accordingly, Plvap-/- (Balb/c, C57Bl/6J, 129Sv/J) mice showed a 
comparable increase in the plasma amounts of larger lipoproteins and cholesterol, and a 
decrease in LDL, HDL, total protein and albumin. The authors argued that the increase in 
larger lipoproteins might be a sequel to hypoproteinemia, which may cause depletion of 
endothelial LPL in animals (Shearer and Kaysen, 2006). We regard this possibility as 
unlikely, as our data clearly show a specific increase in the amounts of chylomicron 
remnants, while the amounts of chylomicrons were unchanged or decreased in the plasma of 
Plvap-/- mice. We suggest that an analysis of the number of fenestrations and their 
permeability to macromolecules in the sinusoids of Plvap-/- (Balb/c, C57Bl/6J, 129Sv/J) mice 
might show similar changes as seen in our study. 
 
For the synthesis of VLDL, hepatocytes require triglycerides which derive from chylomicron 
remnants, from de novo lipogenesis or from albumin-bound fatty acids (Donnelly et al., 
2005). It seems reasonable to assume that the reduced availability of chylomicron remnants 
stimulates Plvap-/- hepatocytes to increase fatty acid synthesis from carbohydrates. Our 
observation of a decrease in the amounts of hepatocyte glycogen supports this assumption. 
A chronic increase in lipogenesis is a contributing factor for non-alcoholic fatty liver disease 
(Kawano and Cohen, 2013) and may well cause or contribute to steatosis in Plvap-/- mice. 
The release of proinflammatory signals from reactive Kupffer cells that ingested chylomicron 
remnants trapped in the sinusoidal lumen are likely to induce steatohepatitis. Consequently, 
hepatocytes of Plvap-/- mice might undergo by apoptosis while HSC might get activated and 
transdifferentiate to activated myofibroblasts, a key event in the pathogenesis of liver fibrosis 
(Guo and Friedman, 2007; Schuppan and Kim, 2013). The number of sinusoidal 
fenestrations decreases significantly in fibrosis (Guo and Friedman, 2007; McGuire et al., 
1992), a process that occurs with the formation of a continuous basal lamina and is termed 
“capillarization” (Schaffner and Poper, 1963). Sinusoidal capillarization may precede liver 
fibrosis, but it is unclear if it has the potential to initiate fibrosis (DeLeve, 2007). Our results 
answer this question since in Plvap-/- mice the targeted null-mutation of an endothelial-
specific molecule primarily induces the lack of sinusoidal fenestrations and only secondarily 
leads to liver fibrosis. 
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5 General discussion 
 
One of the most important functions of endothelial cells is to allow directed passage of 
molecules and solutes across the endothelial barrier. Despite intensive research efforts over 
the recent years, the molecular requirements for transendothelial transport have not been 
clarified conclusively. Here we present results from studies that focused on plasmalemma 
vesicle-associated protein (PLVAP) which is the only known protein so far to be localized to 
diaphragms, thin structures which cover fenestrae and the stomata of caveolae and 
transendothelial channels. The general concept was to investigate the impact of the deletion 
of PLVAP in fenestrated vascular beds in vivo. We expected to obtain more insights into the 
process of fenestrae formation and the function of fenestrae, and additionally to clarify the 
specific function of fenestral diaphragms in transendothelial passage. 
Passage of molecules across endothelial cells may involve transport via cellular vesicles. In 
this context, caveolae and their main structural protein caveolin-1 have been thought to play 
a role in transcytosis and transendothelial transport, along with other functional properties 
involving vascular permeability, tightness of the blood-brain barrier, vascular tone, 
angiogenesis, tumor growth, and atherosclerosis (Bauer et al., 2005; Frank et al., 2003b; 
Hehlgans and Cordes, 2011; Pavlides et al., 2012; Senetta et al., 2013; Sonveaux et al., 
2004).  
Indeed, caveolin-1-deficient mice (Drab et al., 2001; Razani et al., 2001) which lack any 
plasmalemmal caveolae in fibroblasts, endothelial cells, and adipocytes show impaired 
transport of albumin across lung endothelial cells (Schubert et al., 2001). Moreover, the mice 
suffer from other defects in vascular function, from lung abnormalities (i.e. hypercellularity, 
thickened alveolar septa), and decreased vascular tone due to endothelial nitric oxide 
synthase (eNOS) activation. Still, caveolin-1 deficient mice are viable and do not show any 
gross abnormalities neither during embryonic development nor during adulthood (Drab et al., 
2001; Razani et al., 2001). 
Besides the transport of molecules by means of vesicles, specific endothelial cells may 
increase their permeability by the formation of open transcellular pores which span the entire 
thickness of the cell, such as transendothelial pores or fenestrae present in fenestrated 
endothelial cells. Recently, several studies have shown that immune cells, such as 
lymphocytes, can pass across the vascular endothelium by migrating through transcelluar 
pores, a process termed diapedesis (Carman and Springer, 2004; Engelhardt and Wolburg, 
2004; Muller, 2011). Still more common is passage through paracellular pores and several 
proteins are thought to be involved in paracellular leukocyte migration, such as vascular 
endothelial cadherin (VE-cadherin), platelet/endothelial-cell adhesion molecule 1 (PECAM-
1), intercellular adhesion molecule 2 (ICAM2) and CD99 (Ley et al., 2007). During 
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transcellular migration, translocation of intercellular adhesion molecule 1 (ICAM1) expressed 
on the surface of endothelial cells to regions rich in F-actin and caveolin-1 near the cell 
borders, induces the association of several caveolae to form vesiculo-vacuolar organelles 
(VVOs) (Ley et al., 2007; Millán et al., 2006). The VVOs are capable of spanning the entire 
cell, therefore providing channels for leukocytes to migrate to the subendothelial space. 
Indeed, downregulation of caveolin-1 using RNA interference resulted in decreased 
transcellular migration of T-lymphocytes, whereas paracellular migration was unaffected 
(Millán et al., 2006). In the liver, immune cells do not migrate across newly formed 
transcellular pores, but rather use the fenestrae of sinusoids through which they extend 
cytoplasmatic projections into the space of Disse to respond to signals from hepatocytes 
(Jenne and Kubes, 2013).  
In 2009, Keuschnigg and colleagues presented data that linked PLVAP to transcellular 
leukocyte migration across vascular endothelial cells. By studying the process in vitro and in 
vivo the authors observed that PLVAP forms a ring around the transendothelial pore. 
Moreover, PLVAP associates with vimentin, an intermediate filament known to be involved in 
leukocyte migration. PLVAP is redistributed during lymphocyte transmigration and the 
inhibition of PLVAP attenuates inflammation in vivo (Keuschnigg et al., 2009). 
 
 
5.1 PLVAP is required for the formation of diaphragms 
 
The results of our studies clearly show that PLVAP is required for the formation of 
diaphragms covering fenestrae, caveolae, and transendothelial channels. Accordingly, 
diaphragms are completely absent in Plvap-/- mice. Our data were corroborated by a recent 
contribution from Stan and coworkers (Stan et al., 2012). Moreover, Stan and coworkers 
could rescue the phenotype observed in Plvap-/- mice by transgenic complementation. After 
reconstitution, PLVAP was expressed throughout all organs and diaphragms were restored in 
lung, kidney, adrenal gland, pancreas, thyroid, and pancreas (Stan et al., 2012). 
 
 
5.2 Lack of PLVAP leads to embryonic or perinatal lethality 
 
Depending on the genetic background, the deletion of PLVAP in our mouse model leads to 
embryonic lethality. In a pure C57BL/6N background, Plvap-deficient animals die in utero due 
to cardiac malformations, widespread hemorrhages, and edema. Presumable reasons for the 
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lethal phenotype are the hemorrhages and malformations in cardiac morphogenesis. Since 
caveolae with a stomatal diaphragm are the only structures in subcutaneous capillaries with 
an endothelial diaphragm, it is quite likely that those structures are primarily affected. 
Stomatal diaphragms may provide mechanical stability for embryonic capillaries especially 
during the morphogenetic events of angiogenesis including remodeling of capillary walls. The 
absence of stomatal diaphragms upon Plvap deficiency may increase the risk for breaks in 
the endothelial lining, thereby causing hemorrhages and edema. In fact, it has been shown 
that caveolae/caveolin-1 play an important role in cell migration and angiogenesis by 
interacting with VEGF and eNOS (Liu et al., 2002; Maniatis et al., 2006; Navarro et al., 2004; 
Sonveaux et al., 2004). The requirement of caveolae for the proper organization of signaling 
pathways in endothelial cells by providing membrane domains for preformed signaling 
complexes, could be another explanation (Frank et al., 2003b; Lisanti et al., 1994). Those 
pathways could function in both angiogenesis and heart morphogenesis. The fact that the 
deletion of caveolin-1 in mice is not lethal leads to the assumption that the proposed function 
of caveolae in signaling pathways ought to be specific for caveolae with stomatal diaphragms 
and should still be transferred by PLVAP even in the absence of caveolae. Recent data argue 
against this hypothesis as PLVAP is rapidly internalized and degraded in the absence of 
caveolae in caveolin-1-deficient mice (Tkachenko et al., 2012).  
 
Another interesting aspect of my studies is the discovery that Plvap-deficient embryos 
display a higher number of nucleated erythrocytes throughout their circulation. The presence 
of multiple hemorrhages might cause a higher need for oxygen presumably resulting in an 
increased number of nucleated red blood cells. Under normal conditions, nucleated 
erythrocytes persist in the blood stream until about E16 when they are finally replaced by 
mature erythrocytes originating from the liver which becomes the prime fetal hematopoietic 
organ (Keller et al., 1999). An immediate involvement of PLVAP in hematopoiesis could be 
excluded by Stan and colleagues by generating mouse lines with a specific deletion of 
PLVAP in the hematopoietic cell compartments. These mouse lines do not display any 
phenotype at all. Hematopoiesis is not affected and diaphragms are present (Stan et al., 
2012). 
In a mixed C57BL/6N/FVB-N genetic background, Plvap-deficient mice may survive for at 
least 4 weeks. Nevertheless, Plvap-/- mice in the mixed genetic background show severe 
growth retardation and metabolic defects. Genetic background-dependent differences of 
Plvap-/- mice in terms of survival and phenotypic manifestations were also observed by Stan 
and colleagues. They also acknowledge that Plvap-deficient animals in a pure C57BL/6J die 
in utero with no survivors beyond P2, whereas Plvap-deficient animals in a mixed genetic 
background survived till 3-4 or 6-7 month of age, depending on the respective background 
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(Stan et al., 2012). Modifier genes are the most likely reason for the background-dependent 
differences in the phenotype (Doetschman, 2009; Montagutelli, 2000; Yoshiki and Moriwaki, 
2006). It has been shown for numerous genetically modified mouse lines that the genetic 
background can influence the phenotype dramatically. For instance, deletion of keratin 8 in a 
pure FVB/N background leads to colorectal epithelial hyperplasia in adults, while on a 
C57BL/6 background the keratin 8 deficiency causes embryonic lethality, due to abnormal 
liver development (Baribault et al., 1994, 1993). Therefore, first analysis on a mixed 
background is advantageous because it gives a first preview on possible background-
dependent phenotypes. Another reason might be the different approaches used for the 
generation of the Plvap-deficient mice. While we disrupted Plvap gene function by inserting a 
trapping cassette between exon 1 and 2 of Plvap, Stan and colleagues preferred to delete 
exon 2-5 (Stan et al., 2012). 
 
 
5.3 Role of PLVAP in Schlemm's canal endothelial cells and ocular 
capillaries 
 
One aim of my study was to figure out if PLVAP is involved in pore formation in Schlemm's 
canal endothelial cells. Indeed, immunolabeling confirmed the presence of PLVAP in 
endothelial cells of several ocular capillaries, including the capillaries of the choriocapillaris, 
the ciliary body, and the endothelial cells of Schlemm's canal. Furthermore, the examination 
of ocular capillaries provided the same results as the other vascular beds that were 
investigated, such as the exocrine pancreas or the peritubular capillaries of the kidney. 
Again, diaphragms were absent in fenestrae and caveolae. 
 
Since caveolae with a stomatal diaphragm are considerably more numerous in Schlemm's 
canal endothelium than diaphragmed minipores, it is likely that diaphragms of caveolae are 
the primary site of immunolabeling. On the contrary, we also detected immunoreactivity in the 
continuous endothelium of the ventricular endocardium of the embryonic heart, whose 
caveolae are supposed to be devoid of diaphragms (Stan et al., 2012). In addition, our data 
show that PLVAP is expressed in liver sinusoids and glomerular capillaries during embryonic 
development. This finding can be explained by the fact that fenestrae in liver sinusoids and 
glomerular capillaries are bridged by diaphragms during embryonic development (Bankston 
and Pino, 1980), which might be also true for caveolae in the ventricular endocardium of the 
embryonic heart. Furthermore, we found PLVAP expression to be still present in postnatal 
liver, but considerable weaker than in tissues that typically show strong expression of PLVAP 
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such as capillaries of the small intestine or skin. The same results were obtained when 
postnatal kidneys were stained. PLVAP is expressed in glomerular capillaries but weaker 
than in the peritubular capillaries of the kidney interstitium (Figure 33), at least until the age 
of around 3 weeks. The results contradict the opinion that PLVAP is not present in vascular 
beds that lack diaphragm such as liver sinusoids or glomerular capillaries. It rather implicates 
PLVAP is expressed in and localized to the surface of endothelial cells beyond embryonic 
development, even if diaphragms are absent during adulthood. Fenestrae of liver sinusoids 
are dynamic structures which can be induced or decreased due to drugs, toxins, or diseases 
(Braet et al., 1998, 1995). In addition, it has been shown that fenestrae formation can take 
place within 10 min after application of fenestrae-inducing agents, which excludes de novo 
formation of proteins involved in this process (Roberts and Palade, 1995). Rapid pore 
formation during transcellular leukocyte migration supports this idea. Very likely, proteins 
including PLVAP are needed at short notice, supporting the idea that PLVAP might be 
required at or in the membrane of sinusoidal endothelial cells or other endothelial cells with a 
need for dynamic formation of fenestrae, such as the kidney glomerulus. 
 
 
Figure 33: Expression of PLVAP in postnatal kidneys of wild-type animals.  PLVAP is expressed in 
glomerular capillaries of 3-week-old C57BL/6N/FVBN mice. White arrows indicate a glomerulus with positive 
immunoreactivity for PLVAP (red).  
 
 
However, in our Plvap-deficient animals the absence of PLVAP did not provoke any 
alterations in the number of caveolae, similar to the data obtained by an in vitro knock-down 
of Plvap (Stan et al., 2004).  
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5.4 Lack of PLVAP causes a substantial reduction in the number of 
fenestrae in fenestrated endothelial cells 
 
In fenestrated endothelial vessels, fenestrae are typically bridged by a diaphragm. In Plvap-
deficient animals, the presence of endothelial fenestrae is rather diminished than abolished, 
since some fenestrations are still present. The remaining fenestrae without diaphragm are 
not completely empty, but rather contain some fluffy electron-dense material instead, which 
might provide residual filter function to regulate and sustain permeability. Possible candidates 
could be heparan sulfate proteoglycans which have been found on the luminal surfaces of 
endothelial fenestrae providing anionic charges (Simionescu et al., 1981b, 1981c). The 
reduced interstitial spaces in the pancreas of Plvap-deficient animals might point to the more 
than likely reduced transendothelial passage of water and solutes caused by the 
considerable decrease in the number of fenestrations. Also the reduced body size of Plvap-/- 
mice could be attributed to the functional impairment in organs that require fenestrated 
endothelia for normal function. 
 
The fact that fenestrae in our Plvap-deficient animals are not absent, but severely reduced, 
leads to the assumption that PLVAP is not essential for fenestrae formation. However, PLVAP 
might be necessary to maintain size, shape, and distribution of fenestrae by anchoring the 
diaphragms in the rim of the pore, a theory that has been already presented in 1969 
(Clementi and Palade, 1969c). Perfusion of rat intestinal capillaries with EDTA, a Ca-
complexing agent, resulted in the loss of diaphragms and most importantly fenestrae showed 
enlarged diameters and were even replaced by wide discontinuities (Clementi and Palade, 
1969c). These data are additionally supported by an in vitro knockdown of PLVAP by siRNA. 
This approach caused the loss of diaphragms in fenestrae and beyond that, induced 
fenestrae with disrupted morphology, enlarged diameters, and reduced fenestrae density 
(although not significantly) (Ioannidou et al., 2006). 
Based on these conclusions and together with the results we obtained with regards to the 
expression of PLVAP in tissues devoid of structures with a diaphragm, it is reasonable to 
attribute PLVAP, besides being necessary for the formation of diaphragms, an additional role 
in maintenance of fenestrae.  
 
Furthermore, in tissues with a substantial need for restricted permeability and high density of 
fenestrae, open fenestrae due to the loss of the diaphragm might increase the permeability to 
a level that is too high for normal function. Therefore, it might be reasonable for endothelial 
cells to counteract by dismantling fenestrae to reestablish barrier function. However, the 
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basal lamina supporting endothelial cells might act as an additional barrier preventing 
molecules from passing freely across the cells even when fenestrae are more permeable due 
to the loss of their diaphragm, a scenario which Clementi and Palade observed during 
perfusions with EDTA mixed with tracers for electron microscopy. The basement membrane 
was able to prevent the uncontrolled passage of molecules, despite being altered by EDTA 
(Clementi and Palade, 1969c).  
 
 
5.5 PLVAP expression in liver sinusoidal endothelial cells 
 
Despite the common point of view that PLVAP is not expressed in liver sinusoids, we 
obtained opposite results. As already mentioned, I could show that PLVAP is expressed in 
sinusoidal endothelial cells during embryonic development and beyond that also in adult liver 
tissue. That result substantiated the idea of a possible role of PLVAP either in sinusoidal 
fenestrae formation or maintenance or both.  
 
 
5.6 The loss of PLVAP in sinusoidal endothelial cells is associated with 
a lack of fenestrations 
 
Even though liver sinusoids are of the discontinuous type which do not contain diaphragms 
and lack a basement membrane, sinusoidal endothelial cells also showed a remarkable lack 
of fenestrae in our Plvap-deficient mice. Electron microscopy revealed a pronounced 
reduction of sinusoidal openings. These results are quite intriguing, supporting the idea that, 
in addition to being involved in the formation of fenestrae, PLVAP might hold further 
functions, such as maintenance and/or stabilization of those structures.  
 
Therefore, we conclude that PLVAP is also critically required for fenestrations in sinusoidal 
endothelial cells of the liver.  
 
The liver plays a major role in several physiological processes, including digestion, 
metabolism, glycogen storage, detoxification, immune response, and lipid metabolism. 
Endothelial cell openings in liver sinusoids are pivotal for the liver to accomplish its 
physiological functions, because they allow the exchange of molecules between the blood 
and hepatocytes and thus regulate the permeability of sinusoidal endothelial cells.  
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5.7 The lack of fenestrations leads to a decrease in the permeability of 
sinusoidal endothelial cells 
 
It has been shown that the induction of fenestrae in sinusoidal endothelial cells increases 
permeability (Yokomori et al., 2003). In return, the reduction in the amount of fenestrations in 
Plvap-/- mice should influence permeability. Indeed, we were able to show that the reduction 
in the amount of fenestrations in Plvap-/- mice influences permeability negatively. We 
confirmed that the passage of molecules across sinusoidal endothelial cells is dramatically 
impaired.  
Defenestration or capillarization of liver sinusoids has been associated with liver injury in 
several studies (Clark et al., 1988; Horn et al., 1987a; Straub et al., 2008; Van Beers et al., 
2003; Xu et al., 2003). Hepatotoxins, such as ethanol, carbontetrachloride, 
dimethylnitrosamine, thioacetamine, and endotoxin, cause a defenestration of sinusoidal 
endothelial cells, followed by the formation of a basement membrane (Braet and Wisse, 
2002; Xu et al., 2004). Furthermore, defenestration of sinusoidal endothelial cells has been 
linked to the early onset of liver cirrhosis prior accompanied by liver fibrosis (Martinez-
Hernandez and Martinez, 1991; Van Beers et al., 2003). Interestingly, this process is thought 
to be reversible upon removal of the defenestration causing factors (hepatotoxins) but this is 
only possible before the formation of a basement membrane (Xu et al., 2004). Most likely, 
liver fibrosis is induced by hepatic stellate cells, fat storing cells which also comprise the 
majority of retinoids in the body of vertebrates (Blaner et al., 2009). The reduced permeability 
in defenestrated sinusoidal endothelial cells inhibits the uptake of retinol and thus disturbs 
retinol metabolism. This is thought to prompt hepatic stellate cells to produce excessive 
amounts of collagen, which leads to liver fibrosis followed by cirrhosis (Bataller and Brenner, 
2005; Blaner et al., 2009; Mederacke et al., 2013; Moreira, 2007).  
 
 
5.8 Lack of sinusoidal fenestrae in Plvap-deficient mice causes 
hyperlipoproteinemia and steatosis 
 
In Plvap-deficient animals, the reduced permeability of the sinusoidal endothelium 
substantially impairs the passage of lipoproteins between the lumen of liver sinusoids and 
hepatocytes, a scenario which results in massive hyperlipoproteinemia. Obviously, 
chylomicron remnants are not able to pass across the sinusoidal endothelial cells due to the 
lack of open pores. Moreover, VLDL which are formed in the liver are very likely not capable 
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to leave the space of Disse and do not enter the sinusoidal lumen resulting in the reduction 
of plasma low density lipoproteins (LDL). VLDL particles do not accumulate in Disse’s space 
of Plvap-/- mice, as they are very likely drained via hepatic lymphatics into the blood (Fraser 
et al., 1995b). In addition, Plvap-deficient animals display an excessive accumulation of lipids 
in their hepatocytes resulting in multivesicular steatosis (Figure 34). In humans, excessive 
accumulation of lipids in hepatocytes can be induced by alcohol abuse, which is in turn 
known to cause defenestration of liver sinusoids (Horn et al., 1987b). We attribute the 
multivesicular steatosis to the induced fatty acid synthesis in hepatocytes due to the inhibited 
import of essential lipids from circulation, which is in agreement with the decrease of 
glycogen in hepatocytes of Plvap-/- mice. 
Based on our results, we conclude that in Plvap-/- mice, the lack of fenestrae due to the loss 
of PLVAP is responsible for both the massive accumulation of chylomicron remnants in the 
blood and the multivesicular steatosis in hepatocytes which correlates with a decrease in the 
amount of small plasma lipoproteins.  
 
 
Figure 34: Predicted scenario of hyperlipoproteinemia in Plvap-deficient mice.  A In healthy liver 
chylomicron remnants are capable of passing through fenestrae to enter the space of Disse, whereas 
Chylomicrons are excluded due to their size. In turn, VLDL can leave the space of Disse to enter circulation. B 
Sinusoidal endothelial cells in Plvap
-/-
 mice lack fenestrae caused by the absence of PLVAP. As a consequence 
the passage of chylomicron remnants and VLDL is inhibited which results in excessive amounts of lipids in both 
hepatocytes and sinusoids. (Adapted from Le Couteur et al., 2002) 
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Furthermore, increased macrophage recruitment with foam cell formation was observed. 
Foam cells are lipid-laden macrophages/kupffer cells which are known to develop from the 
uptake of excessive lipids during hyperlipoproteinemia (Sano et al., 2004; Yoshimatsu et al., 
2004) 
 
Plvap-/- mice clearly display the typical signs of progressing liver damage including collagen 
deposition by activated hepatic stellate cells in the space of Disse, and the presence of focal 
fibrotic and necrotic areas. Moreover, Plvap-deficient animals show significantly reduced 
levels of total protein and albumin in blood plasma samples, a condition named 
hypoproteinemia which is associated with chronic liver diseases, such as cirrhosis (Blendea 
et al., 2010; Gatta et al., 2012; Rossing et al., 1988; Weigand, 1977). In addition, alanine 
transaminase (ALT) and aspartate transaminase (AST), both parameters for liver damage 
were found to be elevated in the plasma of some animals.  
Stan and colleagues reported recently on the phenotype of Plvap-deficient mice that were 
bred in a genetic background (hybrid intercrosses containing a mix of Balb/c, C57Bl/6J and 
129Sv/J) different from our animals (Stan et al., 2012). The authors observed similar plasma 
changes as reported here. Accordingly, Plvap-/- (Balb/c, C57Bl/6J, 129Sv/J) mice showed an 
increase in chylomicron remnants and cholesterol, and a decrease in LDL, HDL, total protein 
and albumin. The authors argued that the increase in chylomicron remnants might be a 
sequel to hypoproteinemia, which may cause depletion of endothelial LPL in animals. We 
regard this possibility as unlikely, as our data clearly show a specific increase in the amounts 
of chylomicron remnants, while the amounts of chylomicrons were unchanged or decreased 
in the plasma of Plvap-/- mice. We suggest that an analysis of the number of fenestrations 
and their permeability to macromolecules in the sinusoids of Plvap-/- (Balb/c, C57Bl/6J, 
129Sv/J) mice might show similar changes as seen in our study. 
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6 Summary 
 
Plasmalemma vesicle-associated protein (PLVAP), a cationic, endothelial-specific, integral 
membrane glycoprotein is exclusively localized to stomatal and fenestral diaphragms of 
caveolae, transendothelial channels and fenestrae. Fenestral and stomatal diaphragms are 
known to consist of radial fibrils which extend from the peripheral rim of the celllular pore and 
meet in a central mesh. They act as a permselective barrier, regulating permeability by 
allowing the passage of water and solutes but inhibiting the transfer of macromolecules 
across the endothelial barrier. It has been hypothesized that the radial fibrils of diaphragms 
are built by PLVAP dimers.  
To learn about the molecular and biological functions of PLVAP, we generated mutant mice 
that are deficient in PLVAP and characterized their phenotype.  
 
 Depending on the respective genetic background, the deletion of Plvap caused either 
perinatal lethality associated with severe subcutaneous hemorrhages, edema, defects in 
vascular integrity, and cardiac malformations, or early postnatal death at around 4 weeks of 
age. Electron microscopy showed the complete absence of diaphragms in caveolae, 
transendothelial channels, and fenestrae in Plvap-deficient animals.  
In addition, the lack of PLVAP caused a substantial reduction in the number of fenestrae in 
fenestrated vascular beds such as the choroid, the peritubular capillaries of the kidney 
interstitium, or the pancreas. The reduced number of fenestrae caused a restricted 
transendothelial passage of water and solutes, an effect which correlated with a retardation 
of postnatal growth. 
Intriguingly, the deletion of PLVAP also caused lack of fenestrae in non-diaphragmed liver 
sinusoidal cells. Consequently, permeability and the passage of chylomicron remnants and 
other lipoproteins, such as HDL and LDL, was reduced between the lumen of liver sinusoids 
and the hepatocytes, a scenario that caused hyperlipoproteinemia and resulted in liver injury. 
 
In conclusion, PLVAP was identified as an essential structural component of stomatal and 
fenestral diaphragms which are completely absent in endothelial cells of Plvap-deficient 
animals. Furthermore, PLVAP/diaphragms are required for the formation of fenestrations, 
since the loss of diaphragms due to the absence of PLVAP results in a dramatic reduction of 
fenestrations in both fenestrated and discontinuous vascular beds. This effect is 
accompanied by major physiological and metabolic changes such as in the liver where 
fenestrations in sinusoidal endothelial cells are critically required for the passage of 
lipoproteins.  
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ALT   Alanine transaminase 
AP   Aqueous plexus 
AST   Aspartate transaminase 
α-SMA   α-smooth muscle-actin 
B-pore   Border pore 
bp   Base pair 
CB   Ciliary body 
cDNA   Complementary deoxyribonucleic acid 
Ch   Choroid 
Chylo   Chylomicron 
CM   Ciliary muscle 
DAPI   4',6-diamino-2-phenylindol 
DNA   Deoxribonucleic acid 
dNTP   Deoyribonucleotide 
E.   Embryonal day 
ECM   Extracellular matrix  
EGTA   Ethylene glycol tetraacetic acid 
ES   Embryonic stem cells 
FITC-dextran  Fluorescein isothiocyanate-dextran 
GAPDH  Glycerinaldehyde-3-phosphate dehydrogenase 
GNB2L  Guanine nucleotide binding protein, beta polypeptide 2-like 
GV   Giant vacuole 
He   Hepatocyte 
He   Heart 
HRP   horseredish peroxidase 
HUVEC  Human umbilical vein endothelial cells 
H&E   Hematoxylin and Eosin 
I-pore   intracellular pore 
ICP-MS  Inductively coupled plasma mass spectrometry 
In   Intestine 
Is   Islet 
HSC   hepatic stellate cell 
HDL   High density lipoprotein 
LDL   Low density lipoprotein 
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LDLR   Low density lipoprotein receptor 
LRP   Low density lipoprotein receptor-related protein 
LPL   Lipoprotein lipase 
Lu   Lumen 
Lu   Lung 
MECA-32  Mouse panendothelial cell antigen-32 
mRNA   Messenger ribonucleic acid 
OCT   Optimal cooling temperature 
P.   Postnatal day 
Page   Polyacrylamide gel electrophoresis 
PAS   Periodic acid schiff 
PBS   Phosphate buffered saline 
PCR   Polymerase chain reaction 
PFA   Paraformaldehyde 
PLVAP   Plasmalemma vesicle-associated protein 
PPD   P-phenylendiamine 
PT   proximal tubulus 
Re   Retina 
RNA   Ribonucleic acid 
RPE   Retinal pigment epithelium 
RT-PCR  Real-time reverse transcription PCR 
Sc   Sclera 
Sc   Spinal chord 
SC   Schlemm's canal 
SD   Standard deviation 
SD   Stomatal diaphragm 
SDS   Sodium dodecyl sulfate 
SEM   Scanning electron microscopy 
Sk   Skin 
Ss   Scleral spur 
St   Sternum 
TBS   Tris buffered saline 
TEM   Transmission electron microscopy 
TM   Trabecular meshwork 
Tr   Thrombocyte 
VEGF   Vascular endothelial growth factor 
VLDL   Very low density lipoprotein 
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